{"parse":{"title":"Epoxygenase","pageid":20533479,"revid":845145024,"text":{"*":"<div class=\"mw-parser-output\"><p><b>Epoxygenases</b> are a set of membrane-bound, <a href=\"/wiki/Heme\" title=\"Heme\">heme</a>-containing <a href=\"/wiki/Cytochrome_P450\" title=\"Cytochrome P450\">cytochrome P450</a> (CYP P450 or just CYP) enzymes that metabolize <a href=\"/wiki/Polyunsaturated_fatty_acids\" class=\"mw-redirect\" title=\"Polyunsaturated fatty acids\">polyunsaturated fatty acids</a> to <a href=\"/wiki/Epoxide\" title=\"Epoxide\">epoxide</a> products that have a range of biological activities.<sup id=\"cite_ref-Biochim_Biophys_Acta_2014_1-0\" class=\"reference\"><a href=\"#cite_note-Biochim_Biophys_Acta_2014-1\">&#91;1&#93;</a></sup>  The most thoroughly studied substrate of the CYP epoxylgenases is <a href=\"/wiki/Arachidonic_acid\" title=\"Arachidonic acid\">arachidonic acid</a>.  This <a href=\"/wiki/Polyunsaturated_fatty_acid\" title=\"Polyunsaturated fatty acid\">polyunsaturated fatty acid</a> is metabolized by <a href=\"/wiki/Cyclooxygenase\" title=\"Cyclooxygenase\">cyclooxygenases</a> to various <a href=\"/wiki/Prostaglandin\" title=\"Prostaglandin\">prostaglandin</a>, <a href=\"/wiki/Thromboxane\" title=\"Thromboxane\">thromboxane</a>, and <a href=\"/wiki/Prostacyclin\" title=\"Prostacyclin\">prostacyclin</a> metabolites in what has been termed the first pathway of <a href=\"/wiki/Eicosanoid\" title=\"Eicosanoid\">eicosanoid</a> production; it is also metabolized by various <a href=\"/wiki/Lipoxygenases\" class=\"mw-redirect\" title=\"Lipoxygenases\">lipoxygenases</a> to hydroxyeicosatetraenoic acids (e.g. <a href=\"/wiki/5-Hydroxyeicosatetraenoic_acid\" title=\"5-Hydroxyeicosatetraenoic acid\">5-Hydroxyeicosatetraenoic acid</a>, <a href=\"/wiki/12-Hydroxyeicosatetraenoic_acid\" title=\"12-Hydroxyeicosatetraenoic acid\">12-Hydroxyeicosatetraenoic acid</a>, <a href=\"/wiki/15-hydroxyicosatetraenoic_acid\" class=\"mw-redirect\" title=\"15-hydroxyicosatetraenoic acid\">15-hydroxyicosatetraenoic acid</a>) and <a href=\"/wiki/Leukotrienes\" class=\"mw-redirect\" title=\"Leukotrienes\">leukotrienes</a> (e.g. <a href=\"/wiki/Leukotriene_B4\" title=\"Leukotriene B4\">leukotriene B4</a>, <a href=\"/wiki/Leukotriene_C4\" title=\"Leukotriene C4\">leukotriene C4</a>) in what has been termed the second pathway of eicosanoid production. The metabolism of arachidonic acid to <a href=\"/wiki/Epoxyeicosatrienoic_acid\" title=\"Epoxyeicosatrienoic acid\">epoxyeicosatrienoic acids</a> by the CYP epoxygenases has been termed the third pathway of eicosanoid metabolism.<sup id=\"cite_ref-Pharmacol_Ther_2014_2-0\" class=\"reference\"><a href=\"#cite_note-Pharmacol_Ther_2014-2\">&#91;2&#93;</a></sup>  Like the first two pathways of eicosanoid production, this third pathway acts as a signaling pathway wherein a set of enzymes (the epoxygenases) metabolize arachidonic acid to a set of products (the eicosatrienoic acid <a href=\"/wiki/Epoxide\" title=\"Epoxide\">epoxides</a>, abbreviated as EETs, which are classified as <a href=\"/wiki/Nonclassic_eicosanoid\" title=\"Nonclassic eicosanoid\">nonclassic eicosanoids</a>) that act as secondary signals to work in activating their parent or nearby cells and thereby orchestrate functional responses. However, none of these three pathways is limited to metabolizing arachidonic acid to eicosanoids.  Rather, they also metabolize other polyunsaturated fatty acids to products that are structurally analogous to the eicosanoids but often have different bioactivity profiles.  This is particularly true for the CYP epoxygenases which in general act on a broader range of polyunsaturated fatty acids to form a broader range of metabolites than the first and second pathways of eicosanoid production. Furthermore, the latter pathways form metabolites many of which act on cells by binding with and thereby activating specific and well-characterized <a href=\"/wiki/Receptor_(biochemistry)\" title=\"Receptor (biochemistry)\">receptor</a> proteins; no such receptors have been fully characterized for the epoxide metabolites. Finally, there are relatively few metabolite-forming lipoxygenases and cyclooxygenases in the first and second pathways and these oxygenase enzymes share similarity between humans and other mammalian animal models.  The third pathway consists of a large number of metabolite-forming CYP epoxygenases and the human epoxygenases have important differences from those of animal models. Partly because of these differences, it has been difficult to define clear roles for the epoxygenase-epoxide pathways in human physiology and pathology.\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#CYP_epoxygenases\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">CYP epoxygenases</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#CYP_epoxygenase_substrates_and_products\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">CYP epoxygenase substrates and products</span></a></li>\n<li class=\"toclevel-1 tocsection-3\"><a href=\"#Omega-6_fatty_acids\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Omega-6 fatty acids</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-4\"><a href=\"#Arachidonic_acid\"><span class=\"tocnumber\">3.1</span> <span class=\"toctext\">Arachidonic acid</span></a></li>\n<li class=\"toclevel-2 tocsection-5\"><a href=\"#Linoleic_acid\"><span class=\"tocnumber\">3.2</span> <span class=\"toctext\">Linoleic acid</span></a></li>\n<li class=\"toclevel-2 tocsection-6\"><a href=\"#Adrenic_acid\"><span class=\"tocnumber\">3.3</span> <span class=\"toctext\">Adrenic acid</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-7\"><a href=\"#Omega-3_fatty_acids\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">Omega-3 fatty acids</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-8\"><a href=\"#Eicosapentaenoic_acid\"><span class=\"tocnumber\">4.1</span> <span class=\"toctext\">Eicosapentaenoic acid</span></a></li>\n<li class=\"toclevel-2 tocsection-9\"><a href=\"#Docosahexaenoic_acid\"><span class=\"tocnumber\">4.2</span> <span class=\"toctext\">Docosahexaenoic acid</span></a></li>\n<li class=\"toclevel-2 tocsection-10\"><a href=\"#\u03b1-Linolenic_acid\"><span class=\"tocnumber\">4.3</span> <span class=\"toctext\">\u03b1-Linolenic acid</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-11\"><a href=\"#Genetic_polymorphism_in_CYP_epoxygenases\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">Genetic polymorphism in CYP epoxygenases</span></a></li>\n<li class=\"toclevel-1 tocsection-12\"><a href=\"#Genetic_polymorphism_in_Cytochrome_P450_reductase\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">Genetic polymorphism in Cytochrome P450 reductase</span></a></li>\n<li class=\"toclevel-1 tocsection-13\"><a href=\"#References\"><span class=\"tocnumber\">7</span> <span class=\"toctext\">References</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"CYP_epoxygenases\">CYP epoxygenases</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Epoxygenase&amp;action=edit&amp;section=1\" title=\"Edit section: CYP epoxygenases\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The cytochrome P450 (CYP) superfamily of membrane-bound (typically <a href=\"/wiki/Endoplasmic_reticulum\" title=\"Endoplasmic reticulum\">endoplasmic reticulum</a>-bound) enzymes contain a <a href=\"/wiki/Heme\" title=\"Heme\">heme</a> cofactor and therefore are <a href=\"/wiki/Hemoprotein\" class=\"mw-redirect\" title=\"Hemoprotein\">hemoproteins</a>. The superfamily comprises more than 11,000 genes categorized into 1,000 families that are distributed broadly throughout bacteria, <a href=\"/wiki/Archaea\" title=\"Archaea\">archaea</a>, fungi, plants, animals, and even viruses (see <a href=\"/wiki/Cytochrome_P450\" title=\"Cytochrome P450\">Cytochrome P450</a>). The CYP enzymes metabolize an enormously large variety of small and large molecules including foreign chemical substances, i.e. <a href=\"/wiki/Xenobiotic\" title=\"Xenobiotic\">xenobiotics</a> and pharmaceuticals, as well as a diversity of endogenously formed substances such as various <a href=\"/wiki/Steroids\" class=\"mw-redirect\" title=\"Steroids\">steroids</a>, <a href=\"/wiki/Vitamin_D\" title=\"Vitamin D\">vitamin D</a>, <a href=\"/wiki/Bilirubin\" title=\"Bilirubin\">bilirubin</a>, <a href=\"/wiki/Cholesterol\" title=\"Cholesterol\">cholesterol</a>, and fatty acids.<sup id=\"cite_ref-Pharmacol_Ther_2014_2-1\" class=\"reference\"><a href=\"#cite_note-Pharmacol_Ther_2014-2\">&#91;2&#93;</a></sup> Humans have 57 putatively active CYP genes and 58 CYP <a href=\"/wiki/Pseudogenes\" class=\"mw-redirect\" title=\"Pseudogenes\">pseudogenes</a> of which only a few are <a href=\"/wiki/Polyunsaturated_fatty_acid\" title=\"Polyunsaturated fatty acid\">polyunsaturated fatty acid</a> (PUFA) epoxygenases, i.e. enzymes with the capacity to attach atomic oxygen (see <a href=\"/wiki/Allotropes_of_oxygen#Atomic_oxygen\" title=\"Allotropes of oxygen\">Allotropes of oxygen#Atomic oxygen</a>) to the carbon-carbon double bonds of long chain PUFA to form their corresponding epoxides.<sup id=\"cite_ref-Pharmacol_Ther_2014_2-2\" class=\"reference\"><a href=\"#cite_note-Pharmacol_Ther_2014-2\">&#91;2&#93;</a></sup> These CYP epoxygenases represent a family of enzymes that consists of several members of the CYP1 and CYP2 subfamilies.  The metabolism of the straight chain 20-carbon polyunsaturated fatty <a href=\"/wiki/Eicosatetraenoic_acid\" title=\"Eicosatetraenoic acid\">eicosatetraenoic acid</a>, <a href=\"/wiki/Arachidonic_acid\" title=\"Arachidonic acid\">arachidonic acid</a>, by certain CYP epoxygenases is a good example of their action. Arachidonic acid has 4 cis-configured double bonds (see <a href=\"/wiki/Cis%E2%80%93trans_isomerism\" title=\"Cis\u2013trans isomerism\">Cis\u2013trans isomerism</a>) located between carbons 5-6, 8-9, 11-12, and 14-15 <a href=\"/wiki/Double_bond\" title=\"Double bond\">Double bonds</a>. (The cis configuration is  termed <i>Z</i> in the IUPAC <a href=\"/wiki/Chemical_nomenclature\" title=\"Chemical nomenclature\">Chemical nomenclature</a> used here.). It is therefore 5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>-eicosatetraenoic acid.  Certain CYP epoxygenases attack these double bounds to form their respective eicosatrienoic acid epoxide regioisomers (see <a href=\"/wiki/Structural_isomer\" title=\"Structural isomer\">Structural isomer</a>, section on position isomerism [regioisomerism]). The products are therefore 5,6-EET (i.e. 5,6-epoxy-8<i>Z</i>,11<i>Z</i>,14<i>Z</i>-eicosatetrienoic acid), 8,9-EET (i.e. 5,6-epoxy-8<i>Z</i>,11<i>Z</i>,14<i>Z</i>-eicosatetrienoic acid), 11,12-EET (i.e. 11,12-epoxy-5<i>Z</i>,8<i>Z</i>,14<i>Z</i>-eicosatetrienoic acid), and/or 14,15-EET (i.e. 14,15-epoxy-5<i>Z</i>,8<i>Z</i>,11<i>Z</i>-eicosatetrainoic acid, the structure of which is illustrated in the attached figure).  Note that the eicosatetraenoate substrate loses one double bound to become an eicosatrienoic acid with three double bonds and that the epoxygenases typically form a mixture of <i>R</i>/<i>S</i> <a href=\"/wiki/Enantiomers\" class=\"mw-redirect\" title=\"Enantiomers\">enantiomers</a> at the attacked double bound position.  Thus, the CYP epoxygenases which attack arachidonic acid's double bound between carbon 14 and 15 form a mixture of 14<i>R</i>,15<i>S</i>-ETE and 14<i>S</i>,15<i>R</i>-ETE.<sup id=\"cite_ref-Biochim_Biophys_Acta_2014_1-1\" class=\"reference\"><a href=\"#cite_note-Biochim_Biophys_Acta_2014-1\">&#91;1&#93;</a></sup>  However, each CYP epoxygenase often shows preferences in the position of the double bound on which they act, partial selectivity in the <i>R</i>/<i>S</i> enantiomer ratios that they make at each double bound position, and different double bond position preferences and <i>R</i>/<i>S</i> selectivity ratios with different PUFA substrates.<sup id=\"cite_ref-ReferenceB_3-0\" class=\"reference\"><a href=\"#cite_note-ReferenceB-3\">&#91;3&#93;</a></sup>  Finally, the product epoxides are short-lived in cells, generally existing for only several seconds before being converted by a <a href=\"/wiki/Soluble_epoxide_hydrolase\" class=\"mw-redirect\" title=\"Soluble epoxide hydrolase\">Soluble epoxide hydrolase</a> (also termed epoxide hydrolase 2 or sEH) to their corresponding dihydroxy-eicosatetraenoic acid (diHETE) products, e.g. 14,15-HETE rapidly becomes a mixture of 14(<i>S</i>),15(<i>R</i>)-diHETE and 14(<i>R</i>),15(<i>S</i>)-diHETE.<sup id=\"cite_ref-Biochim_Biophys_Acta_2014_1-2\" class=\"reference\"><a href=\"#cite_note-Biochim_Biophys_Acta_2014-1\">&#91;1&#93;</a></sup> Although there are exceptions, the diHETE products are generally far less active than their epoxide precursors; the sEH pathway is therefore regarded as an inactivating pathway which functions to limit epoxide activity.<sup id=\"cite_ref-Biochim_Biophys_Acta_2014_1-3\" class=\"reference\"><a href=\"#cite_note-Biochim_Biophys_Acta_2014-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-4\" class=\"reference\"><a href=\"#cite_note-4\">&#91;4&#93;</a></sup>\n</p><p>The catalytic activity of endoplasmic reticulum-bound cytochrome P450 enzymes, including the epoxygenases, depends upon <a href=\"/wiki/Cytochrome_P450_reductase\" title=\"Cytochrome P450 reductase\">Cytochrome P450 reductase</a> (POR); it transfers <a href=\"/wiki/Electron\" title=\"Electron\">electrons</a> to, and thereby regenerates the activity of, the CYPs.<sup id=\"cite_ref-Pharmacol_Ther_2014_2-3\" class=\"reference\"><a href=\"#cite_note-Pharmacol_Ther_2014-2\">&#91;2&#93;</a></sup>  The human gene that expresses POR is highly polymorphic (see <a href=\"/wiki/Gene_polymorphism\" title=\"Gene polymorphism\">Gene polymorphism</a>); many of the polymorphic variant PORs cause significantly decreases or increases in the activity of the CYPs, including the epoxygenases.<sup id=\"cite_ref-Pharmacol_Ther_2014_2-4\" class=\"reference\"><a href=\"#cite_note-Pharmacol_Ther_2014-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-5\" class=\"reference\"><a href=\"#cite_note-5\">&#91;5&#93;</a></sup>\n</p><p>Scores of drugs have been shown to either inhibit or induce one or more of the CYP epoxygenases;<sup id=\"cite_ref-Pharmacol_Ther_2014_2-5\" class=\"reference\"><a href=\"#cite_note-Pharmacol_Ther_2014-2\">&#91;2&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"CYP_epoxygenase_substrates_and_products\">CYP epoxygenase substrates and products</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Epoxygenase&amp;action=edit&amp;section=2\" title=\"Edit section: CYP epoxygenase substrates and products\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The most studied substrate of the CYP epoxygenases is the <a href=\"/wiki/Omega-6_fatty_acid\" title=\"Omega-6 fatty acid\">omega-6 fatty acid</a>, arachidonic acid.  However, the CYP epoxygenases also metabolize other omega-6 fatty acids such as <a href=\"/wiki/Linoleic_acid\" title=\"Linoleic acid\">linoleic acid</a> and the <a href=\"/wiki/Omega-3_fatty_acid\" title=\"Omega-3 fatty acid\">omega-3 fatty acids</a>, <a href=\"/wiki/Eicosapentaenoic_acid\" title=\"Eicosapentaenoic acid\">eicosapentaenoic acid</a> and <a href=\"/wiki/Docosahexaenoic_acid\" title=\"Docosahexaenoic acid\">docosahexaenoic acid</a>.  The distinction between the omega-6 and omega-3 fatty acid substrates is important because omega-3 fatty acids metabolites can have lesser or different activities than omega-6 fatty acid metabolites; furthermore, they compete with the omega-6 fatty acids for the CYP epoxygenases thereby reducing the production of omega-6 fatty acid metabolites.<sup id=\"cite_ref-Biochim_Biophys_Acta_2014_1-4\" class=\"reference\"><a href=\"#cite_note-Biochim_Biophys_Acta_2014-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-Arch_Biochem_Biophys_2008_6-0\" class=\"reference\"><a href=\"#cite_note-Arch_Biochem_Biophys_2008-6\">&#91;6&#93;</a></sup> The human CYP P450 enzymes identified to have epoxygenase activity on one or more PUFA include <a href=\"/wiki/CYP1A1\" class=\"mw-redirect\" title=\"CYP1A1\">CYP1A1</a>, <a href=\"/wiki/CYP1A2\" title=\"CYP1A2\">CYP1A2</a>, <a href=\"/wiki/CYP2C8\" title=\"CYP2C8\">CYP2C8</a>, <a href=\"/wiki/CYP2C9\" title=\"CYP2C9\">CYP2C9</a>, <a href=\"/wiki/CYP2C18\" title=\"CYP2C18\">CYP2C18</a>, <a href=\"/wiki/CYP2C19\" title=\"CYP2C19\">CYP2C19</a>, <a href=\"/wiki/CYP2E1\" title=\"CYP2E1\">CYP2E1</a>, <a href=\"/wiki/CYP2J2\" title=\"CYP2J2\">CYP2J2</a>, <a href=\"/wiki/CYP2S1\" title=\"CYP2S1\">CYP2S1</a>, <a href=\"/wiki/CYP3A4\" title=\"CYP3A4\">CYP3A4</a>, <a href=\"/wiki/CYP4F2\" title=\"CYP4F2\">CYP4F2</a>, <a href=\"/wiki/CYP4F3\" title=\"CYP4F3\">CYP4F3</a>A, <a href=\"/wiki/CYP4F3\" title=\"CYP4F3\">CYP4F3</a>B, <a href=\"/wiki/CYP4A11\" title=\"CYP4A11\">CYP4A11</a>, <a href=\"/wiki/CYP4F8\" title=\"CYP4F8\">CYP4F8</a>, and <a href=\"/wiki/CYP4F12\" title=\"CYP4F12\">CYP4F12</a>.<sup id=\"cite_ref-ReferenceB_3-1\" class=\"reference\"><a href=\"#cite_note-ReferenceB-3\">&#91;3&#93;</a></sup><sup id=\"cite_ref-Prostaglandins_Other_Lipid_Mediat_2011._p_16_7-0\" class=\"reference\"><a href=\"#cite_note-Prostaglandins_Other_Lipid_Mediat_2011._p_16-7\">&#91;7&#93;</a></sup><sup id=\"cite_ref-ReferenceC_8-0\" class=\"reference\"><a href=\"#cite_note-ReferenceC-8\">&#91;8&#93;</a></sup><sup id=\"cite_ref-9\" class=\"reference\"><a href=\"#cite_note-9\">&#91;9&#93;</a></sup> CYP2C8 and CYP2C9 form particularly large amounts of <a href=\"/wiki/Superoxide\" title=\"Superoxide\">superoxide</a> anion (chemical formula <span class=\"chemf nowrap\">O<span style=\"display:inline-block;margin-bottom:-0.3em;vertical-align:-0.4em;line-height:1em;font-size:80%;text-align:left\"><sup style=\"font-size:inherit;line-height:inherit;vertical-align:baseline\">\u2212</sup><br /><sub style=\"font-size:inherit;line-height:inherit;vertical-align:baseline\">2</sub></span></span>) during their metabolism of polyunsaturated fatty acids; this <a href=\"/wiki/Reactive_oxygen_species\" title=\"Reactive oxygen species\">reactive oxygen species</a> is toxic to cells and may be responsible for some of the activities ascribed to the epoxides made by the two CYPs.<sup id=\"cite_ref-pmid25244930_10-0\" class=\"reference\"><a href=\"#cite_note-pmid25244930-10\">&#91;10&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Omega-6_fatty_acids\">Omega-6 fatty acids</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Epoxygenase&amp;action=edit&amp;section=3\" title=\"Edit section: Omega-6 fatty acids\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<h3><span class=\"mw-headline\" id=\"Arachidonic_acid\">Arachidonic acid</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Epoxygenase&amp;action=edit&amp;section=4\" title=\"Edit section: Arachidonic acid\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>In humans, CYP1A1, CYP1A2, <a href=\"/wiki/CYP2C8\" title=\"CYP2C8\">CYP2C8</a>, <a href=\"/wiki/CYP2C9\" title=\"CYP2C9\">CYP2C9</a>, CYP2C18, CYP2C19, CYP2E1, <a href=\"/wiki/CYP2J2\" title=\"CYP2J2\">CYP2J2</a>, and CYP2S1 <a href=\"/wiki/Isoforms\" class=\"mw-redirect\" title=\"Isoforms\">isoforms</a> metabolize arachidonic acid to <a href=\"/wiki/Epoxyeicosatrienoic_acid\" title=\"Epoxyeicosatrienoic acid\">Epoxyeicosatrienoic acids</a> (i.e., EETs) as defined using  recombinient CYPs in an <i><a href=\"/wiki/In_vitro\" title=\"In vitro\">In vitro</a></i> <a href=\"/wiki/Microsome\" title=\"Microsome\">microsome</a> assay.<sup id=\"cite_ref-Pharmacol_Ther_2014_2-6\" class=\"reference\"><a href=\"#cite_note-Pharmacol_Ther_2014-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-Biochim_Biophys_Acta_2014_1-5\" class=\"reference\"><a href=\"#cite_note-Biochim_Biophys_Acta_2014-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-Arch_Biochem_Biophys_2008_6-1\" class=\"reference\"><a href=\"#cite_note-Arch_Biochem_Biophys_2008-6\">&#91;6&#93;</a></sup><sup id=\"cite_ref-ReferenceC_8-1\" class=\"reference\"><a href=\"#cite_note-ReferenceC-8\">&#91;8&#93;</a></sup><sup id=\"cite_ref-pmid25244930_10-1\" class=\"reference\"><a href=\"#cite_note-pmid25244930-10\">&#91;10&#93;</a></sup> CYP2C9, and CYP2J2 appear to be the main produces of the EETs in humans with CYPP2C9 being the main unsaturated fatty acid epoxide producer in vascular endothelial cells and CYP2J2 being highly expressed (although less catalytically active than CYP2C9) particularly in heart muscle but also in kidneys, pancreas, lung, and brain; CYP2C8, CYP2C19, CYP2J2 are also implicated in converting arachidonic acid to epoxides in humans.<sup id=\"cite_ref-ReferenceA_11-0\" class=\"reference\"><a href=\"#cite_note-ReferenceA-11\">&#91;11&#93;</a></sup> Most of these CYPs preferentially form 14,15-ETE, somewhat lower levels of 11,12-EET, and far lower, trace, or undetectable levels of 8,9-ETE and 4,5-ETE. There are exceptions to this rule with, for example, CYPE1 forming 14,15-EET almost exclusively, CYP2C19 forming 8,9-EET at slightly higher levels than 14,15-EET, and CYP3A4 forming 11,12-EET at slightly higher levels than 14,15-ETE.<sup id=\"cite_ref-Biochim_Biophys_Acta_2014_1-6\" class=\"reference\"><a href=\"#cite_note-Biochim_Biophys_Acta_2014-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-ReferenceA_11-1\" class=\"reference\"><a href=\"#cite_note-ReferenceA-11\">&#91;11&#93;</a></sup>  14,15-EET and 11,12-EET are the major EETs produced by mammalian, including human, tissues.<sup id=\"cite_ref-Biochim_Biophys_Acta_2014_1-7\" class=\"reference\"><a href=\"#cite_note-Biochim_Biophys_Acta_2014-1\">&#91;1&#93;</a></sup>  CYP2C9, CYP2JP, and possibly the more recently characterized CYP2S1 appear to be the main produces of the EETs in humans with CYPP2C9 being the main EET producer in vascular endothelial cells and CYP2JP being highly expressed (although less catalytically active than CYP2C) in heart muscle, kidneys, pancreas, lung, and brain.<sup id=\"cite_ref-ReferenceA_11-2\" class=\"reference\"><a href=\"#cite_note-ReferenceA-11\">&#91;11&#93;</a></sup>  CYP2S1 is expressed in <a href=\"/wiki/Macrophages\" class=\"mw-redirect\" title=\"Macrophages\">macrophages</a>, liver, lung, intestine, and spleen and is abundant in human and mouse <a href=\"/wiki/Atherosclerosis\" title=\"Atherosclerosis\">atherosclerosis</a> (i.e. <a href=\"/wiki/Atheroma\" title=\"Atheroma\">Atheroma</a>) plaques as well as inflamed tonsils.<sup id=\"cite_ref-pmid25244930_10-2\" class=\"reference\"><a href=\"#cite_note-pmid25244930-10\">&#91;10&#93;</a></sup>\nCYP2S1 is expressed in <a href=\"/wiki/Macrophages\" class=\"mw-redirect\" title=\"Macrophages\">macrophages</a>, liver, lung, intestine, and spleen; is abundant in human and mouse <a href=\"/wiki/Atherosclerosis\" title=\"Atherosclerosis\">atherosclerosis</a> (i.e. <a href=\"/wiki/Atheroma\" title=\"Atheroma\">Atheroma</a>) plaques as well as inflamed tonsils; and, in addition to forming epoxides of arachidonic acid (and other polyunsaturated fatty acids), CYP2S1 metabolizes <a href=\"/wiki/Prostaglandin_G2\" title=\"Prostaglandin G2\">prostaglandin G2</a> and <a href=\"/wiki/Prostaglandin_H2\" title=\"Prostaglandin H2\">Prostaglandin H2</a> to <a href=\"/wiki/12-Hydroxyheptadecatrienoic_acid\" title=\"12-Hydroxyheptadecatrienoic acid\">12-Hydroxyheptadecatrienoic acid</a>. Possibly because of metabolizing and thereby inactivating the prostaglandins and/or because forming the bioactive metabolite, 12-hyddroxyheptadecatrienoic acid, rather than EETs, CYP2S1 may act to inhibit the function of <a href=\"/wiki/Monocytes\" class=\"mw-redirect\" title=\"Monocytes\">monocytes</a> and thereby limit <a href=\"/wiki/Inflammation\" title=\"Inflammation\">inflammation</a> as well as other <a href=\"/wiki/Immune_response\" title=\"Immune response\">immune responses</a>.<sup id=\"cite_ref-ReferenceC_8-2\" class=\"reference\"><a href=\"#cite_note-ReferenceC-8\">&#91;8&#93;</a></sup><sup id=\"cite_ref-pmid25244930_10-3\" class=\"reference\"><a href=\"#cite_note-pmid25244930-10\">&#91;10&#93;</a></sup>  The activities and clinical significance of the EETs are given on the <a href=\"/wiki/Epoxyeicosatrienoic_acid\" title=\"Epoxyeicosatrienoic acid\">epoxyeicosatrienoic acid</a> page.\n</p>\n<h3><span class=\"mw-headline\" id=\"Linoleic_acid\">Linoleic acid</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Epoxygenase&amp;action=edit&amp;section=5\" title=\"Edit section: Linoleic acid\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>CYP2C9 and CYP2S1 are known to, and many or all of the other CYPs that act on arachidonic acid are thought to, metabolize the 18 carbon <a href=\"/wiki/Essential_fatty_acid\" title=\"Essential fatty acid\">essential fatty acid</a>, 9(<i>Z</i>),12(<i>Z</i>)-octadecadienoic acid, i.e. <a href=\"/wiki/Linoleic_acid\" title=\"Linoleic acid\">linoleic acid</a>, at is 12,13 carbon-carbon double bout to form (+) and (-) epoxy <a href=\"/wiki/Optical_isomers\" class=\"mw-redirect\" title=\"Optical isomers\">optical isomers</a> viz., the 9<i>S</i>,10<i>R</i>-epoxy-12(<i>Z</i>)-octadecaenoic and 9<i>R</i>,10<i>S</i>-epoxy-12(<i>Z</i>)-octadecaenoic acids; this set of optical isomers is also termed <a href=\"/wiki/Vernolic_acid\" title=\"Vernolic acid\">vernolic acid</a>, linoleic acid 9:10-oxide, and leukotoxin.  CYPC2C9 is known and the other arachidonic acid-metabolizing CYPs are thought to likewise attack linoleic acid at its 9,10 carbon-carbon double bound to form 12<i>S</i>,13<i>R</i>-epoxy-9(<i>Z</i>)-octadecaenoic and 12<i>R</i>,13<i>S</i>-epoxy-9(<i>Z</i>)-octadecaenoic acid optical isomers; this set of optical isomers is also termed <a href=\"/wiki/Coronaric_acid\" title=\"Coronaric acid\">coronaric acid</a>, linoleic acid 12,13-oxide, and isoleukotoxin<sup id=\"cite_ref-Biochim_Biophys_Acta_2014_1-8\" class=\"reference\"><a href=\"#cite_note-Biochim_Biophys_Acta_2014-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-12\" class=\"reference\"><a href=\"#cite_note-12\">&#91;12&#93;</a></sup><sup id=\"cite_ref-13\" class=\"reference\"><a href=\"#cite_note-13\">&#91;13&#93;</a></sup> These linoleic acid-derived leukotoxin and isoleukotoxin sets of optical isomers possess activities similar to that of other leukotoxins such as the pore-forming leukotoxin family of <a href=\"/wiki/RTX_toxin\" title=\"RTX toxin\">RTX toxin</a> virulence factor proteins secreted by <a href=\"/wiki/Gram-negative_bacteria\" title=\"Gram-negative bacteria\">gram-negative bacteria</a>, e.g. <a href=\"/wiki/Aggregatibacter_actinomycetemcomitans\" title=\"Aggregatibacter actinomycetemcomitans\">Aggregatibacter actinomycetemcomitans</a> and <a href=\"/wiki/E._coli\" class=\"mw-redirect\" title=\"E. coli\">E. coli</a>.  That is, they are toxic to leukocytes as well as many other cell types and when injected into rodents produce multiple organ failure and respiratory distress.<sup id=\"cite_ref-Biochim_Biophys_Acta_2014_1-9\" class=\"reference\"><a href=\"#cite_note-Biochim_Biophys_Acta_2014-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-14\" class=\"reference\"><a href=\"#cite_note-14\">&#91;14&#93;</a></sup><sup id=\"cite_ref-pmid10667370_15-0\" class=\"reference\"><a href=\"#cite_note-pmid10667370-15\">&#91;15&#93;</a></sup><sup id=\"cite_ref-16\" class=\"reference\"><a href=\"#cite_note-16\">&#91;16&#93;</a></sup>  These effects appear due to the conversion of leukotoxin to its dihydroxy counterparts, 9<i>S</i>,10<i>R</i>- and 9<i>R</i>,10<i>S</i>-dihydroxy-12(<i>Z</i>)-octadecaenoic acids, and isoleukotoxin to its 12<i>R</i>,13<i>S</i>- and 12<i>S</i>,13<i>R</i>-dihydroxy-9(<i>Z</i>)-octadecenoic acid counterparts by <a href=\"/wiki/Soluble_epoxide_hydrolase\" class=\"mw-redirect\" title=\"Soluble epoxide hydrolase\">soluble epoxide hydrolase</a>.<sup id=\"cite_ref-17\" class=\"reference\"><a href=\"#cite_note-17\">&#91;17&#93;</a></sup>  Some studies suggest but have not proven that leukotoxin and isoleukotoxin, acting primarily if not exclusively through their respective dihydroxy counterparts, are responsible for or contribute to multiple organ failure, respiratory distress, and certain other cataclysmic diseases in humans.<sup id=\"cite_ref-pmid10667370_15-1\" class=\"reference\"><a href=\"#cite_note-pmid10667370-15\">&#91;15&#93;</a></sup><sup id=\"cite_ref-18\" class=\"reference\"><a href=\"#cite_note-18\">&#91;18&#93;</a></sup><sup id=\"cite_ref-19\" class=\"reference\"><a href=\"#cite_note-19\">&#91;19&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Adrenic_acid\">Adrenic acid</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Epoxygenase&amp;action=edit&amp;section=6\" title=\"Edit section: Adrenic acid\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p><a href=\"/wiki/Adrenic_acid\" class=\"mw-redirect\" title=\"Adrenic acid\">Adrenic acid</a> or 7(<i>Z</i>),10(<i>Z</i>),13(<i>Z</i>),16(<i>Z</i>)-docosatetraenoic acid, an abundant fatty acid in the adrenal gland, kidney, vasculature, and early human brain, is metabolized primarily to 7(<i>Z</i>),10(<i>Z</i>),13(<i>Z</i>)-16,17-epoxy-docosatrienoic acid and smaller amounts of its 7,8-, 10,11-, and 13,14-epoxide-docosatrienoic acids by bovine coronary arteries and adrenal zona glomerulosa cells through the apparent action of an unidentified CYP epoxygnease(s); the eSH-dependent metabolism of these eoxide, 7,8-, 10,11-, and 13,14-dihydroxy-docosatrienoic acids relaxes pre-contracted coronary and adrenal gland arteries suggesting that the dihydroxy metabolites may act as vascular endothelium-derived <a href=\"/wiki/Endothelium-derived_relaxing_factor\" title=\"Endothelium-derived relaxing factor\">Endothelium-derived relaxing factors</a>.<sup id=\"cite_ref-pmid26002735_20-0\" class=\"reference\"><a href=\"#cite_note-pmid26002735-20\">&#91;20&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Omega-3_fatty_acids\">Omega-3 fatty acids</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Epoxygenase&amp;action=edit&amp;section=7\" title=\"Edit section: Omega-3 fatty acids\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<h3><span class=\"mw-headline\" id=\"Eicosapentaenoic_acid\">Eicosapentaenoic acid</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Epoxygenase&amp;action=edit&amp;section=8\" title=\"Edit section: Eicosapentaenoic acid\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>5(<i>Z</i>),8(<i>Z</i>),11(<i>Z</i>),14(<i>Z</i>),17(<i>Z</i>)-<a href=\"/wiki/Eicosapentaenoic_acid\" title=\"Eicosapentaenoic acid\">eicosapentaenoic acid</a> (EPA) is metabolized by the same CYP epoxygenases that metabolize arachidonic acid primarily to 17,18-epoxy-5(<i>Z</i>),8(<i>Z</i>),11(<i>Z</i>),14(<i>Z</i>)-eicosatetranoic acid and usually far smaller or undetectable amounts of EPA's 5,6-, 8,9-, 11,12-, or 14,15-epoxides; however, CYP2C9 metabolizes EPA primarily to 14,15-epoxy-5(<i>Z</i>),8(<i>Z</i>),11(<i>Z</i>),17(<i>Z</i>)-eicosatetranoic acid, CYP2C11 forms appreciable amounts of this 14,15-epoxide in addition to the 17,18-epoxide, and CYP2C18 forms appreciable amounts of the 11,12 epoxide (11,12-epoxy-5(<i>Z</i>),8(<i>Z</i>),14(<i>Z</i>),17(<i>Z</i>)-eicosatetranoic acid) in addition to the 17,18-epoxide. Furthermore, CYP4A11, CYP4F8, and CYP4F12, which are CYP monooxygenase rather than CYP epoxygeanse in that they metablize arachidonic acid to monohydroxy eicosatetraenoic acid products (see <a href=\"/wiki/20-Hydroxyeicosatetraenoic_acid\" title=\"20-Hydroxyeicosatetraenoic acid\">20-Hydroxyeicosatetraenoic acid</a>), i.e. 19-hydroxy- and/or 18-hydroxy-eicosatetranoic acids, takes on epoxygease activity in converting EPA primarily to its 17,18-epoxy metabolite (see <a href=\"/wiki/Epoxyeicosatetraenoic_acid\" title=\"Epoxyeicosatetraenoic acid\">epoxyeicosatetraenoic acid</a>).<sup id=\"cite_ref-Prostaglandins_Other_Lipid_Mediat_2011._p_16_7-1\" class=\"reference\"><a href=\"#cite_note-Prostaglandins_Other_Lipid_Mediat_2011._p_16-7\">&#91;7&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Docosahexaenoic_acid\">Docosahexaenoic acid</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Epoxygenase&amp;action=edit&amp;section=9\" title=\"Edit section: Docosahexaenoic acid\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>4(<i>Z</i>),7(<i>Z</i>),10(<i>Z</i>),13(<i>Z</i>),16(<i>Z</i>),19(<i>Z</i>)-<a href=\"/wiki/Docosahexaenoic_acid\" title=\"Docosahexaenoic acid\">docosahexaenoic acid</a> (DHA) is metabolized by the same CYP eoxygenases that metabolize arachidonic acid to form epoxide-containing <a href=\"/wiki/Docosapentaenoic_acid\" title=\"Docosapentaenoic acid\">docosapentaenoic acid</a> products, particularly 19,20-epoxy-4(<i>Z</i>),7(<i>Z</i>),10(<i>Z</i>),13(<i>Z</i>),16(<i>Z</i>)-docosapentenoic acid.<sup id=\"cite_ref-21\" class=\"reference\"><a href=\"#cite_note-21\">&#91;21&#93;</a></sup> These docosapentaenoic acid epoxides or <a href=\"/wiki/Epoxydocosapentaenoic_acid\" title=\"Epoxydocosapentaenoic acid\">Epoxydocosapentaenoic acids</a> (EDPs) have a somewhat different set of activities than, and thereby may serve in part as counterpoises to, the EET's; EDPs may also be responsible for some the beneficial effects attributed to <a href=\"/wiki/Omega-6_fatty_acid\" title=\"Omega-6 fatty acid\">omega-6 fatty acid</a>-rich foods such as <a href=\"/wiki/Fish_oil\" title=\"Fish oil\">fish oil</a> (see <a href=\"/wiki/Epoxydocosapentaenoic_acid\" title=\"Epoxydocosapentaenoic acid\">Epoxydocosapentaenoic acid</a>).<sup id=\"cite_ref-22\" class=\"reference\"><a href=\"#cite_note-22\">&#91;22&#93;</a></sup>\n</p>\n<h3><span id=\".CE.B1-Linolenic_acid\"></span><span class=\"mw-headline\" id=\"\u03b1-Linolenic_acid\">\u03b1-Linolenic acid</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Epoxygenase&amp;action=edit&amp;section=10\" title=\"Edit section: \u03b1-Linolenic acid\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The 18 carbon <a href=\"/wiki/Essential_fatty_acid\" title=\"Essential fatty acid\">essential fatty acid</a>, 9 <a href=\"/wiki/%CE%91-Linolenic_acid\" class=\"mw-redirect\" title=\"\u0391-Linolenic acid\">\u03b1-Linolenic acid</a> or 9(<i>Z</i>),12(<i>Z</i>),15(<i>Z</i>)-octadecatrienoic acid, is metabolized primarily to 9(<i>Z</i>),12(<i>Z</i>)-15,16-epoxy-octadecadienoic acid but also to smaller amounts of its 8,10- and 12,13-epoxides in the serum, liver, lung, and spleen of mice treated with a drug that increases the expression of CYP1A1, CYP1A2 and/or CYP1B1.<sup id=\"cite_ref-pmid26002735_20-1\" class=\"reference\"><a href=\"#cite_note-pmid26002735-20\">&#91;20&#93;</a></sup><sup id=\"cite_ref-23\" class=\"reference\"><a href=\"#cite_note-23\">&#91;23&#93;</a></sup>  These epoxides are also found in the plasma of humans and their levels greatly increase in subjects given an \u03b1-linolenic acid-rich diet.<sup id=\"cite_ref-24\" class=\"reference\"><a href=\"#cite_note-24\">&#91;24&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Genetic_polymorphism_in_CYP_epoxygenases\"><a href=\"/wiki/Genetic_polymorphism\" class=\"mw-redirect\" title=\"Genetic polymorphism\">Genetic polymorphism</a> in CYP epoxygenases</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Epoxygenase&amp;action=edit&amp;section=11\" title=\"Edit section: Genetic polymorphism in CYP epoxygenases\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Human CYP epoxygenase genes come in many <a href=\"/wiki/Single_nucleotide_polymorphism\" class=\"mw-redirect\" title=\"Single nucleotide polymorphism\">single nucleotide polymorphism</a> (SNP) variants some of which code for epoxygenase products with altered activity.  Investigation into the impact of these variants on the bearers' health (i.e. <a href=\"/wiki/Phenotype\" title=\"Phenotype\">phenotype</a>) is an invaluable area of research which offers the opportunity to define the function of the epoxygenases and their polyunsaturated fatty acid metabolites in humans.  However, SNP variants that cause altered polyunsaturated fatty acid metabolism may also cause altered metabolism of their other substrates, i.e. diverse <a href=\"/wiki/Xenobiotic\" title=\"Xenobiotic\">xenobiotic</a> (e.g. <a href=\"/wiki/NSAID\" class=\"mw-redirect\" title=\"NSAID\">NSAID</a>) and endotiotic (e.g. the primary female sex hormone, <a href=\"/wiki/Estradiol\" title=\"Estradiol\">estradiol</a>) compounds: the latter effects may lead to clinical manifestations that overshadow any manifestations resulting from changes in polyunsaturated fatty acid metabolism.\n</p><p>The most common SNP epoxygenase variants are as follows. <b>1)</b> CYP2C8*3 (30411A&gt;G, rs10509681,<sup id=\"cite_ref-25\" class=\"reference\"><a href=\"#cite_note-25\">&#91;25&#93;</a></sup><sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Identifying_reliable_sources\" title=\"Wikipedia:Identifying reliable sources\"><span title=\"The material near this tag may rely on an unreliable source. (January 2017)\">unreliable source?</span></a></i>&#93;</sup> Lys399Arg) converts arachidonic acid to 11,12-EET and 14,15-EET with a turnover rate less than half that of wild type CYP2C8; in a single recent report, male but not female carriers of the CYP2C8*3 allele had an increased risk of essential hypertension.<sup id=\"cite_ref-26\" class=\"reference\"><a href=\"#cite_note-26\">&#91;26&#93;</a></sup> Bearers of this SNP may<sup id=\"cite_ref-27\" class=\"reference\"><a href=\"#cite_note-27\">&#91;27&#93;</a></sup> or may not<sup id=\"cite_ref-28\" class=\"reference\"><a href=\"#cite_note-28\">&#91;28&#93;</a></sup> show increased risk of developing acute gastrointestinal bleeding during the use of <a href=\"/wiki/Non-steroidal_anti-inflammatory_drugs\" class=\"mw-redirect\" title=\"Non-steroidal anti-inflammatory drugs\">non-steroidal anti-inflammatory drugs</a> (NSAIDs) that are its substrates such as <a href=\"/wiki/Aceclofenac\" title=\"Aceclofenac\">aceclofenac</a>, <a href=\"/wiki/Celecoxib\" title=\"Celecoxib\">celecoxib</a>, <a href=\"/wiki/Diclofenac\" title=\"Diclofenac\">diclofenac</a>, <a href=\"/wiki/Ibuprofen\" title=\"Ibuprofen\">ibuprofen</a>, <a href=\"/wiki/Indomethacin\" class=\"mw-redirect\" title=\"Indomethacin\">indomethacin</a>, <a href=\"/wiki/Lornoxicam\" title=\"Lornoxicam\">lornoxicam</a>, <a href=\"/wiki/Meloxicam\" title=\"Meloxicam\">meloxicam</a>, <a href=\"/wiki/Naproxen\" title=\"Naproxen\">naproxen</a>, <a href=\"/wiki/Piroxicam\" title=\"Piroxicam\">piroxicam</a>, <a href=\"/wiki/Tenoxicam\" title=\"Tenoxicam\">tenoxicam</a>, and <a href=\"/wiki/Valdecoxib\" title=\"Valdecoxib\">valdecoxib</a>. <b>2)</b> CYP2J2*7 (\u221276G&gt;T, rs890293,<sup id=\"cite_ref-snpedia.com_29-0\" class=\"reference\"><a href=\"#cite_note-snpedia.com-29\">&#91;29&#93;</a></sup><sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Identifying_reliable_sources\" title=\"Wikipedia:Identifying reliable sources\"><span title=\"The material near this tag may rely on an unreliable source. (January 2017)\">unreliable source?</span></a></i>&#93;</sup> upstream <a href=\"/wiki/Promoter_(genetics)\" title=\"Promoter (genetics)\">Promoter (genetics)</a> site) has decreased binding of the <a href=\"/wiki/Sp1_transcription_factor\" title=\"Sp1 transcription factor\">Sp1 transcription factor</a> resulting in its lowered expressionas and lowered levels of EETs in plasma.  Carriers of this SNP among a <a href=\"/wiki/Uygur\" class=\"mw-redirect\" title=\"Uygur\">Uygur</a> population in China had a higher risk of <a href=\"/wiki/Coronary_artery_disease\" title=\"Coronary artery disease\">coronary artery disease</a>.<sup id=\"cite_ref-snpedia.com_29-1\" class=\"reference\"><a href=\"#cite_note-snpedia.com-29\">&#91;29&#93;</a></sup><sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Identifying_reliable_sources\" title=\"Wikipedia:Identifying reliable sources\"><span title=\"The material near this tag may rely on an unreliable source. (January 2017)\">unreliable source?</span></a></i>&#93;</sup>  However, CYP2J2*7 carriers showed no association with hypertension, heart attack, or stroke in a study of 5,740 participants of the cardiovascular cohort of the Malm\u00f6 Diet and Cancer study; since other studies have afforded contradictory results, this allele is currently regarded as not associated with cardiovascular diseases (see <a href=\"/wiki/Epoxyeicosatrienoic_acid#Clinical_significance\" title=\"Epoxyeicosatrienoic acid\">Epoxyeicosatrienoic acid#Clinical significance</a>).<sup id=\"cite_ref-30\" class=\"reference\"><a href=\"#cite_note-30\">&#91;30&#93;</a></sup>  Bearers of this SNP in a Chinese Population had a higher risk of younger onset of <a href=\"/wiki/Type_2_diabetes\" class=\"mw-redirect\" title=\"Type 2 diabetes\">type 2 diabetes</a> and among a <a href=\"/wiki/Chinese_Han\" class=\"mw-redirect\" title=\"Chinese Han\">Chinese Han</a> population had a higher risk of <a href=\"/wiki/Alzheimer%27s_disease\" title=\"Alzheimer&#39;s disease\">Alzheimer's disease</a>.<sup id=\"cite_ref-snpedia.com_29-2\" class=\"reference\"><a href=\"#cite_note-snpedia.com-29\">&#91;29&#93;</a></sup><sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Identifying_reliable_sources\" title=\"Wikipedia:Identifying reliable sources\"><span title=\"The material near this tag may rely on an unreliable source. (January 2017)\">unreliable source?</span></a></i>&#93;</sup> <b>3)</b> CYP2C8*2 (11054A&gt;T, rs11572103,<sup id=\"cite_ref-31\" class=\"reference\"><a href=\"#cite_note-31\">&#91;31&#93;</a></sup><sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Identifying_reliable_sources\" title=\"Wikipedia:Identifying reliable sources\"><span title=\"The material near this tag may rely on an unreliable source. (January 2017)\">unreliable source?</span></a></i>&#93;</sup> Ile269Phe) and CYP2C8*4 (11041C&gt;, rs1058930,<sup id=\"cite_ref-32\" class=\"reference\"><a href=\"#cite_note-32\">&#91;32&#93;</a></sup><sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Identifying_reliable_sources\" title=\"Wikipedia:Identifying reliable sources\"><span title=\"The material near this tag may rely on an unreliable source. (January 2017)\">unreliable source?</span></a></i>&#93;</sup> variants have reduced arachidonic acid-metabolizing activity but have not been clearly associated with cardiovascular or other diseases.<sup id=\"cite_ref-33\" class=\"reference\"><a href=\"#cite_note-33\">&#91;33&#93;</a></sup> <b>4)</b> CYPC28*4 (3608C&gt;T, rs1058930,<sup id=\"cite_ref-34\" class=\"reference\"><a href=\"#cite_note-34\">&#91;34&#93;</a></sup><sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Identifying_reliable_sources\" title=\"Wikipedia:Identifying reliable sources\"><span title=\"The material near this tag may rely on an unreliable source. (January 2017)\">unreliable source?</span></a></i>&#93;</sup> Ile264Met) has reduced arachidonic acid metabolizing activity. It has not been associated with cardiovascular diseases but has a higher incidence in subjects with <a href=\"/wiki/Type_II_diabetes\" class=\"mw-redirect\" title=\"Type II diabetes\">type II diabetes</a> in a small sample of Caucasians in Germany.<sup id=\"cite_ref-35\" class=\"reference\"><a href=\"#cite_note-35\">&#91;35&#93;</a></sup>  <b>5)</b> The CYP2C9*2 (3608C&gt;T, rs1799853,<sup id=\"cite_ref-36\" class=\"reference\"><a href=\"#cite_note-36\">&#91;36&#93;</a></sup><sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Identifying_reliable_sources\" title=\"Wikipedia:Identifying reliable sources\"><span title=\"The material near this tag may rely on an unreliable source. (January 2017)\">unreliable source?</span></a></i>&#93;</sup> Arg144Cys) variant has a 50% reduction in polyunsaturated fatty acid metabolizing activity compared to CYP2C9 wild type&#160;; carriers of it show no association with cardiovascular disease but exhibit poor metabolism of the anti-coagulating, <i>blood-thining</i> agent, <a href=\"/wiki/Warfarin\" title=\"Warfarin\">warfarin</a>. These carriers are susceptible to the gastrointestinal bleeding side effects of warfarin and the NSAID cited above.<sup id=\"cite_ref-37\" class=\"reference\"><a href=\"#cite_note-37\">&#91;37&#93;</a></sup><sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Identifying_reliable_sources\" title=\"Wikipedia:Identifying reliable sources\"><span title=\"The material near this tag may rely on an unreliable source. (January 2017)\">unreliable source?</span></a></i>&#93;</sup> <b>6 )</b> CYP2C9*3 (42624A&gt;C, rs1057910,<sup id=\"cite_ref-38\" class=\"reference\"><a href=\"#cite_note-38\">&#91;38&#93;</a></sup><sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Identifying_reliable_sources\" title=\"Wikipedia:Identifying reliable sources\"><span title=\"The material near this tag may rely on an unreliable source. (January 2017)\">unreliable source?</span></a></i>&#93;</sup> Iso359Leu) encodes an expoxygenase with reduced arachidonic acid metabolizing activity.  This allele has not been directly associated with cardiovascular diseases but may be associated with the poor metabolism and therefore adverse reactions to warfarin, NSAID,  sulfonylurea-containing oral <a href=\"/wiki/Hypoglycemic_agent\" class=\"mw-redirect\" title=\"Hypoglycemic agent\">hypoglycemic agents</a>, and the anti-(epilepsy) drug, phenytoin.<sup id=\"cite_ref-39\" class=\"reference\"><a href=\"#cite_note-39\">&#91;39&#93;</a></sup><sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Identifying_reliable_sources\" title=\"Wikipedia:Identifying reliable sources\"><span title=\"The material near this tag may rely on an unreliable source. (January 2017)\">unreliable source?</span></a></i>&#93;</sup> <b>7)</b> CYP2C19*2 (19154G&gt;A, rs4244285,<sup id=\"cite_ref-40\" class=\"reference\"><a href=\"#cite_note-40\">&#91;40&#93;</a></sup><sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Identifying_reliable_sources\" title=\"Wikipedia:Identifying reliable sources\"><span title=\"The material near this tag may rely on an unreliable source. (January 2017)\">unreliable source?</span></a></i>&#93;</sup> Il264Met) and CYP2C19*3 (17948G&gt;A, rs4986893,<sup id=\"cite_ref-41\" class=\"reference\"><a href=\"#cite_note-41\">&#91;41&#93;</a></sup><sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Identifying_reliable_sources\" title=\"Wikipedia:Identifying reliable sources\"><span title=\"The material near this tag may rely on an unreliable source. (January 2017)\">unreliable source?</span></a></i>&#93;</sup> His212X) are loss-of-function <a href=\"/wiki/Null_allele\" title=\"Null allele\">null alleles</a>; carriers of the CYP2C19*3 but not the CYP2C19*2 allele showed a <i>reduced</i> risk of developing essential hypertension in a large Korean population study.<sup id=\"cite_ref-42\" class=\"reference\"><a href=\"#cite_note-42\">&#91;42&#93;</a></sup> Bearers of null alleles would be expected to be poor metabolizers of several drugs which are CYP2C19*2 or CYP2C19*3 substrates.  This is particularly the case with <a href=\"/wiki/Clopidogrel\" title=\"Clopidogrel\">Clopidogrel</a>, a drug used to block platelet activation, blood clotting, and thereby heart attack, stroke, and peripheral artery occlusion in people at high risk of these events; CYP2C19 metabolizes clopidogrel to it active form.  Consequently, patients with severe deficiencies in this CYP, i.e.  bearers of CYP2C19*3 or CYP2C19*2 alleles, fail to gain protection from clopidogrel and have a higher risk of the cited cardiovascular events than clopidogrel-treated patients bearing wild type CYP2C19 alleles.<sup id=\"cite_ref-43\" class=\"reference\"><a href=\"#cite_note-43\">&#91;43&#93;</a></sup> <b>8)</b> CYPC19*17 (-800C&gt;T, rs12248560, site<sup id=\"cite_ref-44\" class=\"reference\"><a href=\"#cite_note-44\">&#91;44&#93;</a></sup><sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Identifying_reliable_sources\" title=\"Wikipedia:Identifying reliable sources\"><span title=\"The material near this tag may rely on an unreliable source. (January 2017)\">unreliable source?</span></a></i>&#93;</sup> upstream <a href=\"/wiki/Gene_promoter\" class=\"mw-redirect\" title=\"Gene promoter\">gene promoter</a> site) causes overproduction of its epoxygenase and thereby the ultra fast metabolism of arachidonic acid. Bearers of this allele have not been associated with cardiovascular diseases but clearly show a decreased risk of developing breast cancer and <a href=\"/wiki/Endometriosis\" title=\"Endometriosis\">endometriosis</a> possible because their rapid metabolism of estrogen leads to lower estrogen levels and thereby a lower risk of these estrogen-fueled diseases.<sup id=\"cite_ref-45\" class=\"reference\"><a href=\"#cite_note-45\">&#91;45&#93;</a></sup><sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Identifying_reliable_sources\" title=\"Wikipedia:Identifying reliable sources\"><span title=\"The material near this tag may rely on an unreliable source. (January 2017)\">unreliable source?</span></a></i>&#93;</sup><sup id=\"cite_ref-46\" class=\"reference\"><a href=\"#cite_note-46\">&#91;46&#93;</a></sup><sup id=\"cite_ref-47\" class=\"reference\"><a href=\"#cite_note-47\">&#91;47&#93;</a></sup> These bearers also a higher rate of metabolism of, and therefore reduced responsiveness to, certain <a href=\"/wiki/Proton_pump_inhibitor\" class=\"mw-redirect\" title=\"Proton pump inhibitor\">proton pump inhibitor</a> and <a href=\"/wiki/Antidepressant\" title=\"Antidepressant\">antidepressant</a> drugs.<sup id=\"cite_ref-48\" class=\"reference\"><a href=\"#cite_note-48\">&#91;48&#93;</a></sup><sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Identifying_reliable_sources\" title=\"Wikipedia:Identifying reliable sources\"><span title=\"The material near this tag may rely on an unreliable source. (January 2017)\">unreliable source?</span></a></i>&#93;</sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Genetic_polymorphism_in_Cytochrome_P450_reductase\">Genetic polymorphism in Cytochrome P450 reductase</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Epoxygenase&amp;action=edit&amp;section=12\" title=\"Edit section: Genetic polymorphism in Cytochrome P450 reductase\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>As indicated above, Cytochrome P450 reductase (POR) is responsible for regenerating the activity of CYPs including the epoxygenases. Several genetic variants of the human POR gene impact epoxygenase activity. For example, POR <a href=\"/wiki/Missense_mutation\" title=\"Missense mutation\">Missense mutations</a> A287P<sup id=\"cite_ref-49\" class=\"reference\"><a href=\"#cite_note-49\">&#91;49&#93;</a></sup> and R457H<sup id=\"cite_ref-50\" class=\"reference\"><a href=\"#cite_note-50\">&#91;50&#93;</a></sup> lead to reductions in the activity of CYP2C19 and CYP2C9, respectively, whereas A503V<sup id=\"cite_ref-51\" class=\"reference\"><a href=\"#cite_note-51\">&#91;51&#93;</a></sup> and Q153R<sup id=\"cite_ref-52\" class=\"reference\"><a href=\"#cite_note-52\">&#91;52&#93;</a></sup> missense mutations lead to small increases in the activity of CYP2C9.<sup id=\"cite_ref-Pharmacol_Ther_2014_2-7\" class=\"reference\"><a href=\"#cite_note-Pharmacol_Ther_2014-2\">&#91;2&#93;</a></sup> While these and other POR genetic variants have not yet been associated with epoxygenase-related disease, they contribute to the marked variability in the activity of the epoxygenases between individuals.\n</p>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Epoxygenase&amp;action=edit&amp;section=13\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist columns references-column-width\" style=\"-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;\">\n<ol class=\"references\">\n<li id=\"cite_note-Biochim_Biophys_Acta_2014-1\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Biochim_Biophys_Acta_2014_1-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Biochim_Biophys_Acta_2014_1-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Biochim_Biophys_Acta_2014_1-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Biochim_Biophys_Acta_2014_1-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-Biochim_Biophys_Acta_2014_1-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-Biochim_Biophys_Acta_2014_1-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-Biochim_Biophys_Acta_2014_1-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-Biochim_Biophys_Acta_2014_1-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-Biochim_Biophys_Acta_2014_1-8\"><sup><i><b>i</b></i></sup></a> <a href=\"#cite_ref-Biochim_Biophys_Acta_2014_1-9\"><sup><i><b>j</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Spector, A. A.; Kim, H. Y. (2015). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4314516\">\"Cytochrome P450 epoxygenase pathway of polyunsaturated fatty acid metabolism\"</a>. <i>Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids</i>. <b>1851</b> (4): 356\u201365. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.bbalip.2014.07.020\">10.1016/j.bbalip.2014.07.020</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4314516\">4314516</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25093613\">25093613</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biochimica+et+Biophysica+Acta+%28BBA%29+-+Molecular+and+Cell+Biology+of+Lipids&amp;rft.atitle=Cytochrome+P450+epoxygenase+pathway+of+polyunsaturated+fatty+acid+metabolism&amp;rft.volume=1851&amp;rft.issue=4&amp;rft.pages=356-65&amp;rft.date=2015&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4314516&amp;rft_id=info%3Apmid%2F25093613&amp;rft_id=info%3Adoi%2F10.1016%2Fj.bbalip.2014.07.020&amp;rft.aulast=Spector&amp;rft.aufirst=A.+A.&amp;rft.au=Kim%2C+H.+Y.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4314516&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxygenase\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Pharmacol_Ther_2014-2\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Pharmacol_Ther_2014_2-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Pharmacol_Ther_2014_2-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Pharmacol_Ther_2014_2-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Pharmacol_Ther_2014_2-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-Pharmacol_Ther_2014_2-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-Pharmacol_Ther_2014_2-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-Pharmacol_Ther_2014_2-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-Pharmacol_Ther_2014_2-7\"><sup><i><b>h</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Shahabi, P; Siest, G; Meyer, U. A.; Visvikis-Siest, S (2014). \"Human cytochrome P450 epoxygenases: Variability in expression and role in inflammation-related disorders\". <i>Pharmacology &amp; Therapeutics</i>. <b>144</b> (2): 134\u201361. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.pharmthera.2014.05.011\">10.1016/j.pharmthera.2014.05.011</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/24882266\">24882266</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pharmacology+%26+Therapeutics&amp;rft.atitle=Human+cytochrome+P450+epoxygenases%3A+Variability+in+expression+and+role+in+inflammation-related+disorders&amp;rft.volume=144&amp;rft.issue=2&amp;rft.pages=134-61&amp;rft.date=2014&amp;rft_id=info%3Adoi%2F10.1016%2Fj.pharmthera.2014.05.011&amp;rft_id=info%3Apmid%2F24882266&amp;rft.aulast=Shahabi&amp;rft.aufirst=P&amp;rft.au=Siest%2C+G&amp;rft.au=Meyer%2C+U.+A.&amp;rft.au=Visvikis-Siest%2C+S&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxygenase\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-ReferenceB-3\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-ReferenceB_3-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-ReferenceB_3-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Barbosa-Sicard, E; Markovic, M; Honeck, H; Christ, B; Muller, D. N.; Schunck, W. H. (2005). \"Eicosapentaenoic acid metabolism by cytochrome P450 enzymes of the CYP2C subfamily\". <i>Biochemical and Biophysical Research Communications</i>. <b>329</b> (4): 1275\u201381. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.bbrc.2005.02.103\">10.1016/j.bbrc.2005.02.103</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15766564\">15766564</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biochemical+and+Biophysical+Research+Communications&amp;rft.atitle=Eicosapentaenoic+acid+metabolism+by+cytochrome+P450+enzymes+of+the+CYP2C+subfamily&amp;rft.volume=329&amp;rft.issue=4&amp;rft.pages=1275-81&amp;rft.date=2005&amp;rft_id=info%3Adoi%2F10.1016%2Fj.bbrc.2005.02.103&amp;rft_id=info%3Apmid%2F15766564&amp;rft.aulast=Barbosa-Sicard&amp;rft.aufirst=E&amp;rft.au=Markovic%2C+M&amp;rft.au=Honeck%2C+H&amp;rft.au=Christ%2C+B&amp;rft.au=Muller%2C+D.+N.&amp;rft.au=Schunck%2C+W.+H.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxygenase\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-4\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Harris, T. R.; Hammock, B. D. (2013). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3733540\">\"Soluble epoxide hydrolase: Gene structure, expression and deletion\"</a>. <i>Gene</i>. <b>526</b> (2): 61\u201374. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.gene.2013.05.008\">10.1016/j.gene.2013.05.008</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3733540\">3733540</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23701967\">23701967</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Gene&amp;rft.atitle=Soluble+epoxide+hydrolase%3A+Gene+structure%2C+expression+and+deletion&amp;rft.volume=526&amp;rft.issue=2&amp;rft.pages=61-74&amp;rft.date=2013&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3733540&amp;rft_id=info%3Apmid%2F23701967&amp;rft_id=info%3Adoi%2F10.1016%2Fj.gene.2013.05.008&amp;rft.aulast=Harris&amp;rft.aufirst=T.+R.&amp;rft.au=Hammock%2C+B.+D.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3733540&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxygenase\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-5\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-5\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Hart, S. N.; Zhong, X. B. (2008). \"P450 oxidoreductase: Genetic polymorphisms and implications for drug metabolism and toxicity\". <i>Expert Opinion on Drug Metabolism &amp; Toxicology</i>. <b>4</b> (4): 439\u201352. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1517/17425255.4.4.439\">10.1517/17425255.4.4.439</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18433346\">18433346</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Expert+Opinion+on+Drug+Metabolism+%26+Toxicology&amp;rft.atitle=P450+oxidoreductase%3A+Genetic+polymorphisms+and+implications+for+drug+metabolism+and+toxicity&amp;rft.volume=4&amp;rft.issue=4&amp;rft.pages=439-52&amp;rft.date=2008&amp;rft_id=info%3Adoi%2F10.1517%2F17425255.4.4.439&amp;rft_id=info%3Apmid%2F18433346&amp;rft.aulast=Hart&amp;rft.aufirst=S.+N.&amp;rft.au=Zhong%2C+X.+B.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxygenase\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Arch_Biochem_Biophys_2008-6\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Arch_Biochem_Biophys_2008_6-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Arch_Biochem_Biophys_2008_6-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Fer, M; Dr\u00e9ano, Y; Lucas, D; Corcos, L; Sala\u00fcn, J. P.; Berthou, F; Amet, Y (2008). \"Metabolism of eicosapentaenoic and docosahexaenoic acids by recombinant human cytochromes P450\". <i>Archives of Biochemistry and Biophysics</i>. <b>471</b> (2): 116\u201325. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.abb.2008.01.002\">10.1016/j.abb.2008.01.002</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18206980\">18206980</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Archives+of+Biochemistry+and+Biophysics&amp;rft.atitle=Metabolism+of+eicosapentaenoic+and+docosahexaenoic+acids+by+recombinant+human+cytochromes+P450&amp;rft.volume=471&amp;rft.issue=2&amp;rft.pages=116-25&amp;rft.date=2008&amp;rft_id=info%3Adoi%2F10.1016%2Fj.abb.2008.01.002&amp;rft_id=info%3Apmid%2F18206980&amp;rft.aulast=Fer&amp;rft.aufirst=M&amp;rft.au=Dr%C3%A9ano%2C+Y&amp;rft.au=Lucas%2C+D&amp;rft.au=Corcos%2C+L&amp;rft.au=Sala%C3%BCn%2C+J.+P.&amp;rft.au=Berthou%2C+F&amp;rft.au=Amet%2C+Y&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxygenase\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Prostaglandins_Other_Lipid_Mediat_2011._p_16-7\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Prostaglandins_Other_Lipid_Mediat_2011._p_16_7-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Prostaglandins_Other_Lipid_Mediat_2011._p_16_7-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Westphal, C; Konkel, A; Schunck, W. H. (2011). \"CYP-eicosanoids--a new link between omega-3 fatty acids and cardiac disease?\". <i>Prostaglandins &amp; Other Lipid Mediators</i>. <b>96</b> (1\u20134): 99\u2013108. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.prostaglandins.2011.09.001\">10.1016/j.prostaglandins.2011.09.001</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21945326\">21945326</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Prostaglandins+%26+Other+Lipid+Mediators&amp;rft.atitle=CYP-eicosanoids--a+new+link+between+omega-3+fatty+acids+and+cardiac+disease%3F&amp;rft.volume=96&amp;rft.issue=1%E2%80%934&amp;rft.pages=99-108&amp;rft.date=2011&amp;rft_id=info%3Adoi%2F10.1016%2Fj.prostaglandins.2011.09.001&amp;rft_id=info%3Apmid%2F21945326&amp;rft.aulast=Westphal&amp;rft.aufirst=C&amp;rft.au=Konkel%2C+A&amp;rft.au=Schunck%2C+W.+H.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxygenase\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-ReferenceC-8\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-ReferenceC_8-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-ReferenceC_8-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-ReferenceC_8-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Fr\u00f6mel, T; Kohlstedt, K; Popp, R; Yin, X; Awwad, K; Barbosa-Sicard, E; Thomas, A. C.; Lieberz, R; Mayr, M; Fleming, I (2013). \"Cytochrome P4502S1: A novel monocyte/macrophage fatty acid epoxygenase in human atherosclerotic plaques\". <i>Basic Research in Cardiology</i>. <b>108</b> (1): 319. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s00395-012-0319-8\">10.1007/s00395-012-0319-8</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23224081\">23224081</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Basic+Research+in+Cardiology&amp;rft.atitle=Cytochrome+P4502S1%3A+A+novel+monocyte%2Fmacrophage+fatty+acid+epoxygenase+in+human+atherosclerotic+plaques&amp;rft.volume=108&amp;rft.issue=1&amp;rft.pages=319&amp;rft.date=2013&amp;rft_id=info%3Adoi%2F10.1007%2Fs00395-012-0319-8&amp;rft_id=info%3Apmid%2F23224081&amp;rft.aulast=Fr%C3%B6mel&amp;rft.aufirst=T&amp;rft.au=Kohlstedt%2C+K&amp;rft.au=Popp%2C+R&amp;rft.au=Yin%2C+X&amp;rft.au=Awwad%2C+K&amp;rft.au=Barbosa-Sicard%2C+E&amp;rft.au=Thomas%2C+A.+C.&amp;rft.au=Lieberz%2C+R&amp;rft.au=Mayr%2C+M&amp;rft.au=Fleming%2C+I&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxygenase\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-9\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-9\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bishop-Bailey, D; Thomson, S; Askari, A; Faulkner, A; Wheeler-Jones, C (2014). \"Lipid-metabolizing CYPs in the regulation and dysregulation of metabolism\". <i>Annual Review of Nutrition</i>. <b>34</b>: 261\u201379. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1146/annurev-nutr-071813-105747\">10.1146/annurev-nutr-071813-105747</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/24819323\">24819323</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annual+Review+of+Nutrition&amp;rft.atitle=Lipid-metabolizing+CYPs+in+the+regulation+and+dysregulation+of+metabolism&amp;rft.volume=34&amp;rft.pages=261-79&amp;rft.date=2014&amp;rft_id=info%3Adoi%2F10.1146%2Fannurev-nutr-071813-105747&amp;rft_id=info%3Apmid%2F24819323&amp;rft.aulast=Bishop-Bailey&amp;rft.aufirst=D&amp;rft.au=Thomson%2C+S&amp;rft.au=Askari%2C+A&amp;rft.au=Faulkner%2C+A&amp;rft.au=Wheeler-Jones%2C+C&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxygenase\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid25244930-10\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid25244930_10-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid25244930_10-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid25244930_10-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-pmid25244930_10-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Fleming, I (2014). \"The pharmacology of the cytochrome P450 epoxygenase/soluble epoxide hydrolase axis in the vasculature and cardiovascular disease\". <i>Pharmacological Reviews</i>. <b>66</b> (4): 1106\u201340. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1124/pr.113.007781\">10.1124/pr.113.007781</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25244930\">25244930</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pharmacological+Reviews&amp;rft.atitle=The+pharmacology+of+the+cytochrome+P450+epoxygenase%2Fsoluble+epoxide+hydrolase+axis+in+the+vasculature+and+cardiovascular+disease&amp;rft.volume=66&amp;rft.issue=4&amp;rft.pages=1106-40&amp;rft.date=2014&amp;rft_id=info%3Adoi%2F10.1124%2Fpr.113.007781&amp;rft_id=info%3Apmid%2F25244930&amp;rft.aulast=Fleming&amp;rft.aufirst=I&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxygenase\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-ReferenceA-11\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-ReferenceA_11-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-ReferenceA_11-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-ReferenceA_11-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Yang, L; M\u00e4ki-Pet\u00e4j\u00e4, K; Cheriyan, J; McEniery, C; Wilkinson, I. B. (2015). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4500322\">\"The role of epoxyeicosatrienoic acids in the cardiovascular system\"</a>. <i>British Journal of Clinical Pharmacology</i>. <b>80</b> (1): 28\u201344. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/bcp.12603\">10.1111/bcp.12603</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4500322\">4500322</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25655310\">25655310</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=British+Journal+of+Clinical+Pharmacology&amp;rft.atitle=The+role+of+epoxyeicosatrienoic+acids+in+the+cardiovascular+system&amp;rft.volume=80&amp;rft.issue=1&amp;rft.pages=28-44&amp;rft.date=2015&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4500322&amp;rft_id=info%3Apmid%2F25655310&amp;rft_id=info%3Adoi%2F10.1111%2Fbcp.12603&amp;rft.aulast=Yang&amp;rft.aufirst=L&amp;rft.au=M%C3%A4ki-Pet%C3%A4j%C3%A4%2C+K&amp;rft.au=Cheriyan%2C+J&amp;rft.au=McEniery%2C+C&amp;rft.au=Wilkinson%2C+I.+B.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4500322&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxygenase\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-12\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-12\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Draper, A. J.; Hammock, B. D. (2000). \"Identification of CYP2C9 as a human liver microsomal linoleic acid epoxygenase\". <i>Archives of Biochemistry and Biophysics</i>. <b>376</b> (1): 199\u2013205. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1006/abbi.2000.1705\">10.1006/abbi.2000.1705</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/10729206\">10729206</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Archives+of+Biochemistry+and+Biophysics&amp;rft.atitle=Identification+of+CYP2C9+as+a+human+liver+microsomal+linoleic+acid+epoxygenase&amp;rft.volume=376&amp;rft.issue=1&amp;rft.pages=199-205&amp;rft.date=2000&amp;rft_id=info%3Adoi%2F10.1006%2Fabbi.2000.1705&amp;rft_id=info%3Apmid%2F10729206&amp;rft.aulast=Draper&amp;rft.aufirst=A.+J.&amp;rft.au=Hammock%2C+B.+D.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxygenase\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-13\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-13\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Konkel, A; Schunck, W. H. (2011). \"Role of cytochrome P450 enzymes in the bioactivation of polyunsaturated fatty acids\". <i>Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics</i>. <b>1814</b> (1): 210\u201322. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.bbapap.2010.09.009\">10.1016/j.bbapap.2010.09.009</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20869469\">20869469</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biochimica+et+Biophysica+Acta+%28BBA%29+-+Proteins+and+Proteomics&amp;rft.atitle=Role+of+cytochrome+P450+enzymes+in+the+bioactivation+of+polyunsaturated+fatty+acids&amp;rft.volume=1814&amp;rft.issue=1&amp;rft.pages=210-22&amp;rft.date=2011&amp;rft_id=info%3Adoi%2F10.1016%2Fj.bbapap.2010.09.009&amp;rft_id=info%3Apmid%2F20869469&amp;rft.aulast=Konkel&amp;rft.aufirst=A&amp;rft.au=Schunck%2C+W.+H.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxygenase\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-14\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-14\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Moran, J. H.; Weise, R; Schnellmann, R. G.; Freeman, J. P.; Grant, D. F. (1997). \"Cytotoxicity of linoleic acid diols to renal proximal tubular cells\". <i>Toxicology and Applied Pharmacology</i>. <b>146</b> (1): 53\u20139. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1006/taap.1997.8197\">10.1006/taap.1997.8197</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/9299596\">9299596</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Toxicology+and+Applied+Pharmacology&amp;rft.atitle=Cytotoxicity+of+linoleic+acid+diols+to+renal+proximal+tubular+cells&amp;rft.volume=146&amp;rft.issue=1&amp;rft.pages=53-9&amp;rft.date=1997&amp;rft_id=info%3Adoi%2F10.1006%2Ftaap.1997.8197&amp;rft_id=info%3Apmid%2F9299596&amp;rft.aulast=Moran&amp;rft.aufirst=J.+H.&amp;rft.au=Weise%2C+R&amp;rft.au=Schnellmann%2C+R.+G.&amp;rft.au=Freeman%2C+J.+P.&amp;rft.au=Grant%2C+D.+F.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxygenase\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid10667370-15\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid10667370_15-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid10667370_15-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Greene, J. F.; Hammock, B. D. (1999). \"Toxicity of linoleic acid metabolites\". <i>Advances in Experimental Medicine and Biology</i>. <b>469</b>: 471\u20137. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/978-1-4615-4793-8_69\">10.1007/978-1-4615-4793-8_69</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/10667370\">10667370</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Advances+in+Experimental+Medicine+and+Biology&amp;rft.atitle=Toxicity+of+linoleic+acid+metabolites&amp;rft.volume=469&amp;rft.pages=471-7&amp;rft.date=1999&amp;rft_id=info%3Adoi%2F10.1007%2F978-1-4615-4793-8_69&amp;rft_id=info%3Apmid%2F10667370&amp;rft.aulast=Greene&amp;rft.aufirst=J.+F.&amp;rft.au=Hammock%2C+B.+D.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxygenase\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-16\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-16\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Linhartov\u00e1, I; Bumba, L; Ma\u0161\u00edn, J; Basler, M; Osi\u010dka, R; Kamanov\u00e1, J; Proch\u00e1zkov\u00e1, K; Adkins, I; Hejnov\u00e1-Holubov\u00e1, J; Sad\u00edlkov\u00e1, L; Morov\u00e1, J; Sebo, P (2010). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3034196\">\"RTX proteins: A highly diverse family secreted by a common mechanism\"</a>. <i>FEMS Microbiology Reviews</i>. <b>34</b> (6): 1076\u2013112. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/j.1574-6976.2010.00231.x\">10.1111/j.1574-6976.2010.00231.x</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3034196\">3034196</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20528947\">20528947</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=FEMS+Microbiology+Reviews&amp;rft.atitle=RTX+proteins%3A+A+highly+diverse+family+secreted+by+a+common+mechanism&amp;rft.volume=34&amp;rft.issue=6&amp;rft.pages=1076-112&amp;rft.date=2010&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3034196&amp;rft_id=info%3Apmid%2F20528947&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1574-6976.2010.00231.x&amp;rft.aulast=Linhartov%C3%A1&amp;rft.aufirst=I&amp;rft.au=Bumba%2C+L&amp;rft.au=Ma%C5%A1%C3%ADn%2C+J&amp;rft.au=Basler%2C+M&amp;rft.au=Osi%C4%8Dka%2C+R&amp;rft.au=Kamanov%C3%A1%2C+J&amp;rft.au=Proch%C3%A1zkov%C3%A1%2C+K&amp;rft.au=Adkins%2C+I&amp;rft.au=Hejnov%C3%A1-Holubov%C3%A1%2C+J&amp;rft.au=Sad%C3%ADlkov%C3%A1%2C+L&amp;rft.au=Morov%C3%A1%2C+J&amp;rft.au=Sebo%2C+P&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3034196&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxygenase\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-17\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-17\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Greene, J. F.; Newman, J. W.; Williamson, K. C.; Hammock, B. D. (2000). \"Toxicity of epoxy fatty acids and related compounds to cells expressing human soluble epoxide hydrolase\". <i>Chemical research in toxicology</i>. <b>13</b> (4): 217\u201326. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1021/tx990162c\">10.1021/tx990162c</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/10775319\">10775319</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Chemical+research+in+toxicology&amp;rft.atitle=Toxicity+of+epoxy+fatty+acids+and+related+compounds+to+cells+expressing+human+soluble+epoxide+hydrolase&amp;rft.volume=13&amp;rft.issue=4&amp;rft.pages=217-26&amp;rft.date=2000&amp;rft_id=info%3Adoi%2F10.1021%2Ftx990162c&amp;rft_id=info%3Apmid%2F10775319&amp;rft.aulast=Greene&amp;rft.aufirst=J.+F.&amp;rft.au=Newman%2C+J.+W.&amp;rft.au=Williamson%2C+K.+C.&amp;rft.au=Hammock%2C+B.+D.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxygenase\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-18\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-18\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Zheng, J; Plopper, C. G.; Lakritz, J; Storms, D. H.; Hammock, B. D. (2001). \"Leukotoxin-diol: A putative toxic mediator involved in acute respiratory distress syndrome\". <i>American Journal of Respiratory Cell and Molecular Biology</i>. <b>25</b> (4): 434\u20138. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1165/ajrcmb.25.4.4104\">10.1165/ajrcmb.25.4.4104</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11694448\">11694448</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=American+Journal+of+Respiratory+Cell+and+Molecular+Biology&amp;rft.atitle=Leukotoxin-diol%3A+A+putative+toxic+mediator+involved+in+acute+respiratory+distress+syndrome&amp;rft.volume=25&amp;rft.issue=4&amp;rft.pages=434-8&amp;rft.date=2001&amp;rft_id=info%3Adoi%2F10.1165%2Fajrcmb.25.4.4104&amp;rft_id=info%3Apmid%2F11694448&amp;rft.aulast=Zheng&amp;rft.aufirst=J&amp;rft.au=Plopper%2C+C.+G.&amp;rft.au=Lakritz%2C+J&amp;rft.au=Storms%2C+D.+H.&amp;rft.au=Hammock%2C+B.+D.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxygenase\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-19\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-19\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Edwards, L. M.; Lawler, N. G.; Nikolic, S. B.; Peters, J. M.; Horne, J; Wilson, R; Davies, N. W.; Sharman, J. E. (2012). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3413237\">\"Metabolomics reveals increased isoleukotoxin diol (12,13-DHOME) in human plasma after acute Intralipid infusion\"</a>. <i>The Journal of Lipid Research</i>. <b>53</b> (9): 1979\u201386. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1194/jlr.P027706\">10.1194/jlr.P027706</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3413237\">3413237</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/22715155\">22715155</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Lipid+Research&amp;rft.atitle=Metabolomics+reveals+increased+isoleukotoxin+diol+%2812%2C13-DHOME%29+in+human+plasma+after+acute+Intralipid+infusion&amp;rft.volume=53&amp;rft.issue=9&amp;rft.pages=1979-86&amp;rft.date=2012&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3413237&amp;rft_id=info%3Apmid%2F22715155&amp;rft_id=info%3Adoi%2F10.1194%2Fjlr.P027706&amp;rft.aulast=Edwards&amp;rft.aufirst=L.+M.&amp;rft.au=Lawler%2C+N.+G.&amp;rft.au=Nikolic%2C+S.+B.&amp;rft.au=Peters%2C+J.+M.&amp;rft.au=Horne%2C+J&amp;rft.au=Wilson%2C+R&amp;rft.au=Davies%2C+N.+W.&amp;rft.au=Sharman%2C+J.+E.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3413237&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxygenase\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid26002735-20\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid26002735_20-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid26002735_20-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation book\">Westphal C, Konkel A, Schunck WH (2015). \"Cytochrome P450 Enzymes in the Bioactivation of Polyunsaturated Fatty Acids and Their Role in Cardiovascular Disease\".  In Hrycay EG, Bandiera SM. <i>Monooxygenase, Peroxidase and Peroxygenase Properties and Mechanisms of Cytochrome P450</i>. Advances in Experimental Medicine and Biology. <b>851</b>. pp.&#160;151\u201387. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/978-3-319-16009-2_6\">10.1007/978-3-319-16009-2_6</a>. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-3-319-16008-5\" title=\"Special:BookSources/978-3-319-16008-5\">978-3-319-16008-5</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/26002735\">26002735</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Cytochrome+P450+Enzymes+in+the+Bioactivation+of+Polyunsaturated+Fatty+Acids+and+Their+Role+in+Cardiovascular+Disease&amp;rft.btitle=Monooxygenase%2C+Peroxidase+and+Peroxygenase+Properties+and+Mechanisms+of+Cytochrome+P450&amp;rft.series=Advances+in+Experimental+Medicine+and+Biology&amp;rft.pages=151-87&amp;rft.date=2015&amp;rft_id=info%3Apmid%2F26002735&amp;rft_id=info%3Adoi%2F10.1007%2F978-3-319-16009-2_6&amp;rft.isbn=978-3-319-16008-5&amp;rft.aulast=Westphal&amp;rft.aufirst=C&amp;rft.au=Konkel%2C+A&amp;rft.au=Schunck%2C+WH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxygenase\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-21\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-21\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Wagner, K; Inceoglu, B; Hammock, B. D. (2011). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3215909\">\"Soluble epoxide hydrolase inhibition, epoxygenated fatty acids and nociception\"</a>. <i>Prostaglandins &amp; Other Lipid Mediators</i>. <b>96</b> (1\u20134): 76\u201383. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.prostaglandins.2011.08.001\">10.1016/j.prostaglandins.2011.08.001</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3215909\">3215909</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21854866\">21854866</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Prostaglandins+%26+Other+Lipid+Mediators&amp;rft.atitle=Soluble+epoxide+hydrolase+inhibition%2C+epoxygenated+fatty+acids+and+nociception&amp;rft.volume=96&amp;rft.issue=1%E2%80%934&amp;rft.pages=76-83&amp;rft.date=2011&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3215909&amp;rft_id=info%3Apmid%2F21854866&amp;rft_id=info%3Adoi%2F10.1016%2Fj.prostaglandins.2011.08.001&amp;rft.aulast=Wagner&amp;rft.aufirst=K&amp;rft.au=Inceoglu%2C+B&amp;rft.au=Hammock%2C+B.+D.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3215909&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxygenase\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-22\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-22\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Zhang, G; Kodani, S; Hammock, B. D. (2014). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3914417\">\"Stabilized epoxygenated fatty acids regulate inflammation, pain, angiogenesis and cancer\"</a>. <i>Progress in Lipid Research</i>. <b>53</b>: 108\u201323. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.plipres.2013.11.003\">10.1016/j.plipres.2013.11.003</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3914417\">3914417</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/24345640\">24345640</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Progress+in+Lipid+Research&amp;rft.atitle=Stabilized+epoxygenated+fatty+acids+regulate+inflammation%2C+pain%2C+angiogenesis+and+cancer&amp;rft.volume=53&amp;rft.pages=108-23&amp;rft.date=2014&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3914417&amp;rft_id=info%3Apmid%2F24345640&amp;rft_id=info%3Adoi%2F10.1016%2Fj.plipres.2013.11.003&amp;rft.aulast=Zhang&amp;rft.aufirst=G&amp;rft.au=Kodani%2C+S&amp;rft.au=Hammock%2C+B.+D.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3914417&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxygenase\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-23\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-23\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Yang, J; Solaimani, P; Dong, H; Hammock, B; Hankinson, O (2013). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4068614\">\"Treatment of mice with 2,3,7,8-Tetrachlorodibenzo-p-dioxin markedly increases the levels of a number of cytochrome P450 metabolites of omega-3 polyunsaturated fatty acids in the liver and lung\"</a>. <i>The Journal of toxicological sciences</i>. <b>38</b> (6): 833\u20136. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.2131/jts.38.833\">10.2131/jts.38.833</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4068614\">4068614</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/24213002\">24213002</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+toxicological+sciences&amp;rft.atitle=Treatment+of+mice+with+2%2C3%2C7%2C8-Tetrachlorodibenzo-p-dioxin+markedly+increases+the+levels+of+a+number+of+cytochrome+P450+metabolites+of+omega-3+polyunsaturated+fatty+acids+in+the+liver+and+lung&amp;rft.volume=38&amp;rft.issue=6&amp;rft.pages=833-6&amp;rft.date=2013&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4068614&amp;rft_id=info%3Apmid%2F24213002&amp;rft_id=info%3Adoi%2F10.2131%2Fjts.38.833&amp;rft.aulast=Yang&amp;rft.aufirst=J&amp;rft.au=Solaimani%2C+P&amp;rft.au=Dong%2C+H&amp;rft.au=Hammock%2C+B&amp;rft.au=Hankinson%2C+O&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4068614&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxygenase\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-24\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-24\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Holt, R. R.; Yim, S. J.; Shearer, G. C.; Hackman, R. M.; Djurica, D; Newman, J. W.; Shindel, A. W.; Keen, C. L. (2015). \"Effects of short-term walnut consumption on human microvascular function and its relationship to plasma epoxide content\". <i>The Journal of Nutritional Biochemistry</i>. <b>26</b> (12): 1458\u201366. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.jnutbio.2015.07.012\">10.1016/j.jnutbio.2015.07.012</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/26396054\">26396054</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Nutritional+Biochemistry&amp;rft.atitle=Effects+of+short-term+walnut+consumption+on+human+microvascular+function+and+its+relationship+to+plasma+epoxide+content&amp;rft.volume=26&amp;rft.issue=12&amp;rft.pages=1458-66&amp;rft.date=2015&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jnutbio.2015.07.012&amp;rft_id=info%3Apmid%2F26396054&amp;rft.aulast=Holt&amp;rft.aufirst=R.+R.&amp;rft.au=Yim%2C+S.+J.&amp;rft.au=Shearer%2C+G.+C.&amp;rft.au=Hackman%2C+R.+M.&amp;rft.au=Djurica%2C+D&amp;rft.au=Newman%2C+J.+W.&amp;rft.au=Shindel%2C+A.+W.&amp;rft.au=Keen%2C+C.+L.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxygenase\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-25\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-25\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external free\" href=\"http://www.snpedia.com/index.php/Rs10509681\">http://www.snpedia.com/index.php/Rs10509681</a></span>\n</li>\n<li id=\"cite_note-26\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-26\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Tzveova, R; Naydenova, G; Yaneva, T; Dimitrov, G; Vandeva, S; Matrozova, Y; Pendicheva-Duhlenska, D; Popov, I; Beltheva, O; Naydenov, C; Tarnovska-Kadreva, R; Nachev, G; Mitev, V; Kaneva, R (2015). \"Gender-Specific Effect of CYP2C8*3 on the Risk of Essential Hypertension in Bulgarian Patients\". <i>Biochemical Genetics</i>. <b>53</b> (11\u201312): 319\u201333. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s10528-015-9696-7\">10.1007/s10528-015-9696-7</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/26404779\">26404779</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biochemical+Genetics&amp;rft.atitle=Gender-Specific+Effect+of+CYP2C8%2A3+on+the+Risk+of+Essential+Hypertension+in+Bulgarian+Patients&amp;rft.volume=53&amp;rft.issue=11%E2%80%9312&amp;rft.pages=319-33&amp;rft.date=2015&amp;rft_id=info%3Adoi%2F10.1007%2Fs10528-015-9696-7&amp;rft_id=info%3Apmid%2F26404779&amp;rft.aulast=Tzveova&amp;rft.aufirst=R&amp;rft.au=Naydenova%2C+G&amp;rft.au=Yaneva%2C+T&amp;rft.au=Dimitrov%2C+G&amp;rft.au=Vandeva%2C+S&amp;rft.au=Matrozova%2C+Y&amp;rft.au=Pendicheva-Duhlenska%2C+D&amp;rft.au=Popov%2C+I&amp;rft.au=Beltheva%2C+O&amp;rft.au=Naydenov%2C+C&amp;rft.au=Tarnovska-Kadreva%2C+R&amp;rft.au=Nachev%2C+G&amp;rft.au=Mitev%2C+V&amp;rft.au=Kaneva%2C+R&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxygenase\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-27\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-27\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ag\u00fandez, J. A.; Garc\u00eda-Mart\u00edn, E; Mart\u00ednez, C (2009). \"Genetically based impairment in CYP2C8- and CYP2C9-dependent NSAID metabolism as a risk factor for gastrointestinal bleeding: Is a combination of pharmacogenomics and metabolomics required to improve personalized medicine?\". <i>Expert Opinion on Drug Metabolism &amp; Toxicology</i>. <b>5</b> (6): 607\u201320. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1517/17425250902970998\">10.1517/17425250902970998</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19422321\">19422321</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Expert+Opinion+on+Drug+Metabolism+%26+Toxicology&amp;rft.atitle=Genetically+based+impairment+in+CYP2C8-+and+CYP2C9-dependent+NSAID+metabolism+as+a+risk+factor+for+gastrointestinal+bleeding%3A+Is+a+combination+of+pharmacogenomics+and+metabolomics+required+to+improve+personalized+medicine%3F&amp;rft.volume=5&amp;rft.issue=6&amp;rft.pages=607-20&amp;rft.date=2009&amp;rft_id=info%3Adoi%2F10.1517%2F17425250902970998&amp;rft_id=info%3Apmid%2F19422321&amp;rft.aulast=Ag%C3%BAndez&amp;rft.aufirst=J.+A.&amp;rft.au=Garc%C3%ADa-Mart%C3%ADn%2C+E&amp;rft.au=Mart%C3%ADnez%2C+C&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxygenase\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-28\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-28\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Daily, E. B.; Aquilante, C. L. (2009). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2778050\">\"Cytochrome P450 2C8 pharmacogenetics: A review of clinical studies\"</a>. <i>Pharmacogenomics</i>. <b>10</b> (9): 1489\u2013510. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.2217/pgs.09.82\">10.2217/pgs.09.82</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2778050\">2778050</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19761371\">19761371</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pharmacogenomics&amp;rft.atitle=Cytochrome+P450+2C8+pharmacogenetics%3A+A+review+of+clinical+studies&amp;rft.volume=10&amp;rft.issue=9&amp;rft.pages=1489-510&amp;rft.date=2009&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2778050&amp;rft_id=info%3Apmid%2F19761371&amp;rft_id=info%3Adoi%2F10.2217%2Fpgs.09.82&amp;rft.aulast=Daily&amp;rft.aufirst=E.+B.&amp;rft.au=Aquilante%2C+C.+L.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2778050&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxygenase\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-snpedia.com-29\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-snpedia.com_29-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-snpedia.com_29-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-snpedia.com_29-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external free\" href=\"http://www.snpedia.com/index.php/Rs890293\">http://www.snpedia.com/index.php/Rs890293</a></span>\n</li>\n<li id=\"cite_note-30\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-30\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Fava, C; Montagnana, M; Almgren, P; Hedblad, B; Engstr\u00f6m, G; Berglund, G; Minuz, P; Melander, O (2010). \"The common functional polymorphism -50G&gt;T of the CYP2J2 gene is not associated with ischemic coronary and cerebrovascular events in an urban-based sample of Swedes\". <i>Journal of Hypertension</i>. <b>28</b> (2): 294\u20139. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1097/HJH.0b013e328333097e\">10.1097/HJH.0b013e328333097e</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19851119\">19851119</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Hypertension&amp;rft.atitle=The+common+functional+polymorphism+-50G%3ET+of+the+CYP2J2+gene+is+not+associated+with+ischemic+coronary+and+cerebrovascular+events+in+an+urban-based+sample+of+Swedes&amp;rft.volume=28&amp;rft.issue=2&amp;rft.pages=294-9&amp;rft.date=2010&amp;rft_id=info%3Adoi%2F10.1097%2FHJH.0b013e328333097e&amp;rft_id=info%3Apmid%2F19851119&amp;rft.aulast=Fava&amp;rft.aufirst=C&amp;rft.au=Montagnana%2C+M&amp;rft.au=Almgren%2C+P&amp;rft.au=Hedblad%2C+B&amp;rft.au=Engstr%C3%B6m%2C+G&amp;rft.au=Berglund%2C+G&amp;rft.au=Minuz%2C+P&amp;rft.au=Melander%2C+O&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxygenase\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-31\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-31\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external free\" href=\"http://www.snpedia.com/index.php/Rs11572103\">http://www.snpedia.com/index.php/Rs11572103</a></span>\n</li>\n<li id=\"cite_note-32\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-32\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external free\" href=\"http://www.snpedia.com/index.php/Rs1058930\">http://www.snpedia.com/index.php/Rs1058930</a></span>\n</li>\n<li id=\"cite_note-33\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-33\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Daily, E. B.; Aquilante, C. L. (2009). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2778050\">\"Cytochrome P450 2C8 pharmacogenetics: A review of clinical studies\"</a>. <i>Pharmacogenomics</i>. <b>10</b> (9): 1489\u2013510. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.2217/pgs.09.82\">10.2217/pgs.09.82</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2778050\">2778050</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19761371\">19761371</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pharmacogenomics&amp;rft.atitle=Cytochrome+P450+2C8+pharmacogenetics%3A+A+review+of+clinical+studies&amp;rft.volume=10&amp;rft.issue=9&amp;rft.pages=1489-510&amp;rft.date=2009&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2778050&amp;rft_id=info%3Apmid%2F19761371&amp;rft_id=info%3Adoi%2F10.2217%2Fpgs.09.82&amp;rft.aulast=Daily&amp;rft.aufirst=E.+B.&amp;rft.au=Aquilante%2C+C.+L.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2778050&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxygenase\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-34\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-34\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external free\" href=\"http://www.snpedia.com/index.php/Rs1058930\">http://www.snpedia.com/index.php/Rs1058930</a></span>\n</li>\n<li id=\"cite_note-35\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-35\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Weise, A; Prause, S; Eidens, M; Weber, M. M.; Kann, P. H.; Forst, T; Pf\u00fctzner, A (2010). \"Prevalence of CYP450 gene variations in patients with type 2 diabetes\". <i>Clinical laboratory</i>. <b>56</b> (7\u20138): 311\u20138. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20857895\">20857895</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+laboratory&amp;rft.atitle=Prevalence+of+CYP450+gene+variations+in+patients+with+type+2+diabetes&amp;rft.volume=56&amp;rft.issue=7%E2%80%938&amp;rft.pages=311-8&amp;rft.date=2010&amp;rft_id=info%3Apmid%2F20857895&amp;rft.aulast=Weise&amp;rft.aufirst=A&amp;rft.au=Prause%2C+S&amp;rft.au=Eidens%2C+M&amp;rft.au=Weber%2C+M.+M.&amp;rft.au=Kann%2C+P.+H.&amp;rft.au=Forst%2C+T&amp;rft.au=Pf%C3%BCtzner%2C+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxygenase\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-36\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-36\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external free\" href=\"http://www.snpedia.com/index.php/Rs1799853\">http://www.snpedia.com/index.php/Rs1799853</a></span>\n</li>\n<li id=\"cite_note-37\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-37\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external free\" href=\"http://www.snpedia.com/index.php/Rs1799853\">http://www.snpedia.com/index.php/Rs1799853</a></span>\n</li>\n<li id=\"cite_note-38\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-38\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external free\" href=\"http://www.snpedia.com/index.php/Rs1057910\">http://www.snpedia.com/index.php/Rs1057910</a></span>\n</li>\n<li id=\"cite_note-39\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-39\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external free\" href=\"http://www.snpedia.com/index.php/Rs1057910\">http://www.snpedia.com/index.php/Rs1057910</a></span>\n</li>\n<li id=\"cite_note-40\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-40\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external free\" href=\"http://www.snpedia.com/index.php/Rs4244285\">http://www.snpedia.com/index.php/Rs4244285</a></span>\n</li>\n<li id=\"cite_note-41\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-41\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external free\" href=\"http://www.snpedia.com/index.php/Rs4986893\">http://www.snpedia.com/index.php/Rs4986893</a></span>\n</li>\n<li id=\"cite_note-42\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-42\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Shin, D. J.; Kwon, J; Park, A. R.; Bae, Y; Shin, E. S.; Park, S; Jang, Y (2012). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3481368\">\"Association of CYP2C19*2 and *3 genetic variants with essential hypertension in Koreans\"</a>. <i>Yonsei Medical Journal</i>. <b>53</b> (6): 1113\u20139. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.3349/ymj.2012.53.6.1113\">10.3349/ymj.2012.53.6.1113</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3481368\">3481368</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23074110\">23074110</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Yonsei+Medical+Journal&amp;rft.atitle=Association+of+CYP2C19%2A2+and+%2A3+genetic+variants+with+essential+hypertension+in+Koreans&amp;rft.volume=53&amp;rft.issue=6&amp;rft.pages=1113-9&amp;rft.date=2012&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3481368&amp;rft_id=info%3Apmid%2F23074110&amp;rft_id=info%3Adoi%2F10.3349%2Fymj.2012.53.6.1113&amp;rft.aulast=Shin&amp;rft.aufirst=D.+J.&amp;rft.au=Kwon%2C+J&amp;rft.au=Park%2C+A.+R.&amp;rft.au=Bae%2C+Y&amp;rft.au=Shin%2C+E.+S.&amp;rft.au=Park%2C+S&amp;rft.au=Jang%2C+Y&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3481368&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxygenase\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-43\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-43\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Beitelshees, A. L.; Horenstein, R. B.; Vesely, M. R.; Mehra, M. R.; Shuldiner, A. R. (2011). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3235907\">\"Pharmacogenetics and clopidogrel response in patients undergoing percutaneous coronary interventions\"</a>. <i>Clinical Pharmacology &amp; Therapeutics</i>. <b>89</b> (3): 455\u20139. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/clpt.2010.316\">10.1038/clpt.2010.316</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3235907\">3235907</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21270785\">21270785</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Pharmacology+%26+Therapeutics&amp;rft.atitle=Pharmacogenetics+and+clopidogrel+response+in+patients+undergoing+percutaneous+coronary+interventions&amp;rft.volume=89&amp;rft.issue=3&amp;rft.pages=455-9&amp;rft.date=2011&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3235907&amp;rft_id=info%3Apmid%2F21270785&amp;rft_id=info%3Adoi%2F10.1038%2Fclpt.2010.316&amp;rft.aulast=Beitelshees&amp;rft.aufirst=A.+L.&amp;rft.au=Horenstein%2C+R.+B.&amp;rft.au=Vesely%2C+M.+R.&amp;rft.au=Mehra%2C+M.+R.&amp;rft.au=Shuldiner%2C+A.+R.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3235907&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxygenase\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-44\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-44\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external free\" href=\"http://www.snpedia.com/index.php/Rs12248560\">http://www.snpedia.com/index.php/Rs12248560</a></span>\n</li>\n<li id=\"cite_note-45\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-45\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external free\" href=\"http://www.snpedia.com/index.php/Rs12248560\">http://www.snpedia.com/index.php/Rs12248560</a></span>\n</li>\n<li id=\"cite_note-46\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-46\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Justenhoven, C; Hamann, U; Pierl, C. B.; Baisch, C; Harth, V; Rabstein, S; Spickenheuer, A; Pesch, B; Br\u00fcning, T; Winter, S; Ko, Y. D.; Brauch, H (2009). \"CYP2C19*17 is associated with decreased breast cancer risk\". <i>Breast Cancer Research and Treatment</i>. <b>115</b> (2): 391\u20136. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s10549-008-0076-4\">10.1007/s10549-008-0076-4</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18521743\">18521743</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Breast+Cancer+Research+and+Treatment&amp;rft.atitle=CYP2C19%2A17+is+associated+with+decreased+breast+cancer+risk&amp;rft.volume=115&amp;rft.issue=2&amp;rft.pages=391-6&amp;rft.date=2009&amp;rft_id=info%3Adoi%2F10.1007%2Fs10549-008-0076-4&amp;rft_id=info%3Apmid%2F18521743&amp;rft.aulast=Justenhoven&amp;rft.aufirst=C&amp;rft.au=Hamann%2C+U&amp;rft.au=Pierl%2C+C.+B.&amp;rft.au=Baisch%2C+C&amp;rft.au=Harth%2C+V&amp;rft.au=Rabstein%2C+S&amp;rft.au=Spickenheuer%2C+A&amp;rft.au=Pesch%2C+B&amp;rft.au=Br%C3%BCning%2C+T&amp;rft.au=Winter%2C+S&amp;rft.au=Ko%2C+Y.+D.&amp;rft.au=Brauch%2C+H&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxygenase\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-47\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-47\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Painter, J. N.; Nyholt, D. R.; Krause, L; Zhao, Z. Z.; Chapman, B; Zhang, C; Medland, S; Martin, N. G.; Kennedy, S; Treloar, S; Zondervan, K; Montgomery, G. W. (2014). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4150687\">\"Common variants in the CYP2C19 gene are associated with susceptibility to endometriosis\"</a>. <i>Fertility and Sterility</i>. <b>102</b> (2): 496\u2013502.e5. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.fertnstert.2014.04.015\">10.1016/j.fertnstert.2014.04.015</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4150687\">4150687</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/24796765\">24796765</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Fertility+and+Sterility&amp;rft.atitle=Common+variants+in+the+CYP2C19+gene+are+associated+with+susceptibility+to+endometriosis&amp;rft.volume=102&amp;rft.issue=2&amp;rft.pages=496-502.e5&amp;rft.date=2014&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4150687&amp;rft_id=info%3Apmid%2F24796765&amp;rft_id=info%3Adoi%2F10.1016%2Fj.fertnstert.2014.04.015&amp;rft.aulast=Painter&amp;rft.aufirst=J.+N.&amp;rft.au=Nyholt%2C+D.+R.&amp;rft.au=Krause%2C+L&amp;rft.au=Zhao%2C+Z.+Z.&amp;rft.au=Chapman%2C+B&amp;rft.au=Zhang%2C+C&amp;rft.au=Medland%2C+S&amp;rft.au=Martin%2C+N.+G.&amp;rft.au=Kennedy%2C+S&amp;rft.au=Treloar%2C+S&amp;rft.au=Zondervan%2C+K&amp;rft.au=Montgomery%2C+G.+W.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4150687&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpoxygenase\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-48\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-48\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external free\" href=\"http://www.snpedia.com/index.php/Rs12248560\">http://www.snpedia.com/index.php/Rs12248560</a></span>\n</li>\n<li id=\"cite_note-49\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-49\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external free\" href=\"http://cancer.sanger.ac.uk/cosmic/mutation/overview?id=215444\">http://cancer.sanger.ac.uk/cosmic/mutation/overview?id=215444</a></span>\n</li>\n<li id=\"cite_note-50\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-50\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external free\" href=\"http://cancer.sanger.ac.uk/cosmic/mutation/overview?id=1581970\">http://cancer.sanger.ac.uk/cosmic/mutation/overview?id=1581970</a></span>\n</li>\n<li id=\"cite_note-51\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-51\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external free\" href=\"https://www.snpedia.com/index.php/Rs1057868\">https://www.snpedia.com/index.php/Rs1057868</a></span>\n</li>\n<li id=\"cite_note-52\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-52\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external free\" href=\"http://cancer.sanger.ac.uk/cosmic/mutation/overview?id=1075652\">http://cancer.sanger.ac.uk/cosmic/mutation/overview?id=1075652</a></span>\n</li>\n</ol></div>\n\n<!-- \nNewPP limit report\nParsed by mw1247\nCached time: 20180908070925\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.628 seconds\nReal time usage: 0.688 seconds\nPreprocessor visited node count: 4686/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 121252/2097152 bytes\nTemplate argument size: 9005/2097152 bytes\nHighest expansion depth: 16/40\nExpensive parser function count: 1/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 74580/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.333/10.000 seconds\nLua memory usage: 4.01 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  571.529      1 -total\n 59.88%  342.226      1 Template:Reflist\n 40.86%  233.504     33 Template:Cite_journal\n 28.90%  165.172     16 Template:Unreliable_source?\n 25.90%  148.048     16 Template:Fix\n 16.91%   96.649     16 Template:Delink\n  7.37%   42.123     16 Template:Category_handler\n  5.30%   30.269      1 Template:Chem\n  4.43%   25.314      1 Template:Chem/link\n  3.51%   20.077      3 Template:Chem/atom\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:20533479-0!canonical and timestamp 20180908070924 and revision id 845145024\n -->\n</div>"},"langlinks":[],"categories":[{"sortkey":"","hidden":"","*":"All_articles_lacking_reliable_references"},{"sortkey":"","hidden":"","*":"Articles_lacking_reliable_references_from_January_2017"},{"sortkey":"","*":"Enzymes"},{"sortkey":"","*":"Inflammations"}],"links":[{"ns":14,"exists":"","*":"Category:Articles lacking reliable references from January 2017"},{"ns":0,"exists":"","*":"12-Hydroxyeicosatetraenoic acid"},{"ns":0,"exists":"","*":"12-Hydroxyheptadecatrienoic acid"},{"ns":0,"exists":"","*":"15-hydroxyicosatetraenoic acid"},{"ns":0,"exists":"","*":"20-Hydroxyeicosatetraenoic acid"},{"ns":0,"exists":"","*":"5-Hydroxyeicosatetraenoic acid"},{"ns":0,"exists":"","*":"Aceclofenac"},{"ns":0,"exists":"","*":"Adrenic acid"},{"ns":0,"exists":"","*":"Aggregatibacter actinomycetemcomitans"},{"ns":0,"exists":"","*":"Allotropes of oxygen"},{"ns":0,"exists":"","*":"Alzheimer's disease"},{"ns":0,"exists":"","*":"Antidepressant"},{"ns":0,"exists":"","*":"Arachidonic acid"},{"ns":0,"exists":"","*":"Archaea"},{"ns":0,"exists":"","*":"Atheroma"},{"ns":0,"exists":"","*":"Atherosclerosis"},{"ns":0,"exists":"","*":"Bilirubin"},{"ns":0,"exists":"","*":"CYP1A1"},{"ns":0,"exists":"","*":"CYP1A2"},{"ns":0,"exists":"","*":"CYP2C18"},{"ns":0,"exists":"","*":"CYP2C19"},{"ns":0,"exists":"","*":"CYP2C8"},{"ns":0,"exists":"","*":"CYP2C9"},{"ns":0,"exists":"","*":"CYP2E1"},{"ns":0,"exists":"","*":"CYP2J2"},{"ns":0,"exists":"","*":"CYP2S1"},{"ns":0,"exists":"","*":"CYP3A4"},{"ns":0,"exists":"","*":"CYP4A11"},{"ns":0,"exists":"","*":"CYP4F12"},{"ns":0,"exists":"","*":"CYP4F2"},{"ns":0,"exists":"","*":"CYP4F3"},{"ns":0,"exists":"","*":"CYP4F8"},{"ns":0,"exists":"","*":"Celecoxib"},{"ns":0,"exists":"","*":"Chemical nomenclature"},{"ns":0,"exists":"","*":"Chinese Han"},{"ns":0,"exists":"","*":"Cholesterol"},{"ns":0,"exists":"","*":"Cis\u2013trans isomerism"},{"ns":0,"exists":"","*":"Clopidogrel"},{"ns":0,"exists":"","*":"Coronaric acid"},{"ns":0,"exists":"","*":"Coronary artery disease"},{"ns":0,"exists":"","*":"Cyclooxygenase"},{"ns":0,"exists":"","*":"Cytochrome P450"},{"ns":0,"exists":"","*":"Cytochrome P450 reductase"},{"ns":0,"exists":"","*":"Diclofenac"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Docosahexaenoic acid"},{"ns":0,"exists":"","*":"Docosapentaenoic acid"},{"ns":0,"exists":"","*":"Double bond"},{"ns":0,"exists":"","*":"E. coli"},{"ns":0,"exists":"","*":"Eicosanoid"},{"ns":0,"exists":"","*":"Eicosapentaenoic acid"},{"ns":0,"exists":"","*":"Eicosatetraenoic acid"},{"ns":0,"exists":"","*":"Electron"},{"ns":0,"exists":"","*":"Enantiomers"},{"ns":0,"exists":"","*":"Endometriosis"},{"ns":0,"exists":"","*":"Endoplasmic reticulum"},{"ns":0,"exists":"","*":"Endothelium-derived relaxing factor"},{"ns":0,"exists":"","*":"Epoxide"},{"ns":0,"exists":"","*":"Epoxydocosapentaenoic acid"},{"ns":0,"exists":"","*":"Epoxyeicosatetraenoic acid"},{"ns":0,"exists":"","*":"Epoxyeicosatrienoic acid"},{"ns":0,"exists":"","*":"Essential fatty acid"},{"ns":0,"exists":"","*":"Estradiol"},{"ns":0,"exists":"","*":"Fish oil"},{"ns":0,"exists":"","*":"Gene polymorphism"},{"ns":0,"exists":"","*":"Gene promoter"},{"ns":0,"exists":"","*":"Genetic polymorphism"},{"ns":0,"exists":"","*":"Gram-negative bacteria"},{"ns":0,"exists":"","*":"Heme"},{"ns":0,"exists":"","*":"Hemoprotein"},{"ns":0,"exists":"","*":"Hypoglycemic agent"},{"ns":0,"exists":"","*":"Ibuprofen"},{"ns":0,"exists":"","*":"Immune response"},{"ns":0,"exists":"","*":"In vitro"},{"ns":0,"exists":"","*":"Indomethacin"},{"ns":0,"exists":"","*":"Inflammation"},{"ns":0,"exists":"","*":"International Standard Book Number"},{"ns":0,"exists":"","*":"Isoforms"},{"ns":0,"exists":"","*":"Leukotriene B4"},{"ns":0,"exists":"","*":"Leukotriene C4"},{"ns":0,"exists":"","*":"Leukotrienes"},{"ns":0,"exists":"","*":"Linoleic acid"},{"ns":0,"exists":"","*":"Lipoxygenases"},{"ns":0,"exists":"","*":"Lornoxicam"},{"ns":0,"exists":"","*":"Macrophages"},{"ns":0,"exists":"","*":"Meloxicam"},{"ns":0,"exists":"","*":"Microsome"},{"ns":0,"exists":"","*":"Missense mutation"},{"ns":0,"exists":"","*":"Monocytes"},{"ns":0,"exists":"","*":"NSAID"},{"ns":0,"exists":"","*":"Naproxen"},{"ns":0,"exists":"","*":"Non-steroidal anti-inflammatory drugs"},{"ns":0,"exists":"","*":"Nonclassic eicosanoid"},{"ns":0,"exists":"","*":"Null allele"},{"ns":0,"exists":"","*":"Omega-3 fatty acid"},{"ns":0,"exists":"","*":"Omega-6 fatty acid"},{"ns":0,"exists":"","*":"Optical isomers"},{"ns":0,"exists":"","*":"Phenotype"},{"ns":0,"exists":"","*":"Piroxicam"},{"ns":0,"exists":"","*":"Polyunsaturated fatty acid"},{"ns":0,"exists":"","*":"Polyunsaturated fatty acids"},{"ns":0,"exists":"","*":"Promoter (genetics)"},{"ns":0,"exists":"","*":"Prostacyclin"},{"ns":0,"exists":"","*":"Prostaglandin"},{"ns":0,"exists":"","*":"Prostaglandin G2"},{"ns":0,"exists":"","*":"Prostaglandin H2"},{"ns":0,"exists":"","*":"Proton pump inhibitor"},{"ns":0,"exists":"","*":"Pseudogenes"},{"ns":0,"exists":"","*":"PubMed Central"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"RTX toxin"},{"ns":0,"exists":"","*":"Reactive oxygen species"},{"ns":0,"exists":"","*":"Receptor (biochemistry)"},{"ns":0,"exists":"","*":"Single nucleotide polymorphism"},{"ns":0,"exists":"","*":"Soluble epoxide hydrolase"},{"ns":0,"exists":"","*":"Sp1 transcription factor"},{"ns":0,"exists":"","*":"Steroids"},{"ns":0,"exists":"","*":"Structural isomer"},{"ns":0,"exists":"","*":"Superoxide"},{"ns":0,"exists":"","*":"Tenoxicam"},{"ns":0,"exists":"","*":"Thromboxane"},{"ns":0,"exists":"","*":"Type 2 diabetes"},{"ns":0,"exists":"","*":"Type II diabetes"},{"ns":0,"exists":"","*":"Uygur"},{"ns":0,"exists":"","*":"Valdecoxib"},{"ns":0,"exists":"","*":"Vernolic acid"},{"ns":0,"exists":"","*":"Vitamin D"},{"ns":0,"exists":"","*":"Warfarin"},{"ns":0,"exists":"","*":"Xenobiotic"},{"ns":0,"exists":"","*":"\u0391-Linolenic acid"},{"ns":4,"exists":"","*":"Wikipedia:Identifying reliable sources"}],"templates":[{"ns":10,"exists":"","*":"Template:Chem"},{"ns":10,"exists":"","*":"Template:Chem/link"},{"ns":10,"exists":"","*":"Template:Chem/atom"},{"ns":10,"exists":"","*":"Template:Su"},{"ns":10,"exists":"","*":"Template:Unreliable source?"},{"ns":10,"exists":"","*":"Template:Fix"},{"ns":10,"exists":"","*":"Template:Category handler"},{"ns":10,"exists":"","*":"Template:Fix/category"},{"ns":10,"exists":"","*":"Template:Delink"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Column-width"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Cite book"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":828,"exists":"","*":"Module:Su"},{"ns":828,"exists":"","*":"Module:Unsubst"},{"ns":828,"exists":"","*":"Module:Category handler"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Category handler/data"},{"ns":828,"exists":"","*":"Module:Category handler/config"},{"ns":828,"exists":"","*":"Module:Category handler/shared"},{"ns":828,"exists":"","*":"Module:Category handler/blacklist"},{"ns":828,"exists":"","*":"Module:Namespace detect/data"},{"ns":828,"exists":"","*":"Module:Namespace detect/config"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:Delink"},{"ns":828,"exists":"","*":"Module:No globals"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"}],"images":["Lock-green.svg"],"externallinks":["//www.ncbi.nlm.nih.gov/pmc/articles/PMC4314516","//doi.org/10.1016/j.bbalip.2014.07.020","//www.ncbi.nlm.nih.gov/pubmed/25093613","//doi.org/10.1016/j.pharmthera.2014.05.011","//www.ncbi.nlm.nih.gov/pubmed/24882266","//doi.org/10.1016/j.bbrc.2005.02.103","//www.ncbi.nlm.nih.gov/pubmed/15766564","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3733540","//doi.org/10.1016/j.gene.2013.05.008","//www.ncbi.nlm.nih.gov/pubmed/23701967","//doi.org/10.1517/17425255.4.4.439","//www.ncbi.nlm.nih.gov/pubmed/18433346","//doi.org/10.1016/j.abb.2008.01.002","//www.ncbi.nlm.nih.gov/pubmed/18206980","//doi.org/10.1016/j.prostaglandins.2011.09.001","//www.ncbi.nlm.nih.gov/pubmed/21945326","//doi.org/10.1007/s00395-012-0319-8","//www.ncbi.nlm.nih.gov/pubmed/23224081","//doi.org/10.1146/annurev-nutr-071813-105747","//www.ncbi.nlm.nih.gov/pubmed/24819323","//doi.org/10.1124/pr.113.007781","//www.ncbi.nlm.nih.gov/pubmed/25244930","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4500322","//doi.org/10.1111/bcp.12603","//www.ncbi.nlm.nih.gov/pubmed/25655310","//doi.org/10.1006/abbi.2000.1705","//www.ncbi.nlm.nih.gov/pubmed/10729206","//doi.org/10.1016/j.bbapap.2010.09.009","//www.ncbi.nlm.nih.gov/pubmed/20869469","//doi.org/10.1006/taap.1997.8197","//www.ncbi.nlm.nih.gov/pubmed/9299596","//doi.org/10.1007/978-1-4615-4793-8_69","//www.ncbi.nlm.nih.gov/pubmed/10667370","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3034196","//doi.org/10.1111/j.1574-6976.2010.00231.x","//www.ncbi.nlm.nih.gov/pubmed/20528947","//doi.org/10.1021/tx990162c","//www.ncbi.nlm.nih.gov/pubmed/10775319","//doi.org/10.1165/ajrcmb.25.4.4104","//www.ncbi.nlm.nih.gov/pubmed/11694448","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3413237","//doi.org/10.1194/jlr.P027706","//www.ncbi.nlm.nih.gov/pubmed/22715155","//doi.org/10.1007/978-3-319-16009-2_6","//www.ncbi.nlm.nih.gov/pubmed/26002735","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3215909","//doi.org/10.1016/j.prostaglandins.2011.08.001","//www.ncbi.nlm.nih.gov/pubmed/21854866","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3914417","//doi.org/10.1016/j.plipres.2013.11.003","//www.ncbi.nlm.nih.gov/pubmed/24345640","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4068614","//doi.org/10.2131/jts.38.833","//www.ncbi.nlm.nih.gov/pubmed/24213002","//doi.org/10.1016/j.jnutbio.2015.07.012","//www.ncbi.nlm.nih.gov/pubmed/26396054","//doi.org/10.1007/s10528-015-9696-7","//www.ncbi.nlm.nih.gov/pubmed/26404779","//doi.org/10.1517/17425250902970998","//www.ncbi.nlm.nih.gov/pubmed/19422321","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2778050","//doi.org/10.2217/pgs.09.82","//www.ncbi.nlm.nih.gov/pubmed/19761371","//doi.org/10.1097/HJH.0b013e328333097e","//www.ncbi.nlm.nih.gov/pubmed/19851119","//www.ncbi.nlm.nih.gov/pubmed/20857895","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3481368","//doi.org/10.3349/ymj.2012.53.6.1113","//www.ncbi.nlm.nih.gov/pubmed/23074110","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3235907","//doi.org/10.1038/clpt.2010.316","//www.ncbi.nlm.nih.gov/pubmed/21270785","//doi.org/10.1007/s10549-008-0076-4","//www.ncbi.nlm.nih.gov/pubmed/18521743","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4150687","//doi.org/10.1016/j.fertnstert.2014.04.015","//www.ncbi.nlm.nih.gov/pubmed/24796765","http://www.snpedia.com/index.php/Rs10509681","http://www.snpedia.com/index.php/Rs890293","http://www.snpedia.com/index.php/Rs11572103","http://www.snpedia.com/index.php/Rs1058930","http://www.snpedia.com/index.php/Rs1799853","http://www.snpedia.com/index.php/Rs1057910","http://www.snpedia.com/index.php/Rs4244285","http://www.snpedia.com/index.php/Rs4986893","http://www.snpedia.com/index.php/Rs12248560","http://cancer.sanger.ac.uk/cosmic/mutation/overview?id=215444","http://cancer.sanger.ac.uk/cosmic/mutation/overview?id=1581970","https://www.snpedia.com/index.php/Rs1057868","http://cancer.sanger.ac.uk/cosmic/mutation/overview?id=1075652"],"sections":[{"toclevel":1,"level":"2","line":"CYP epoxygenases","number":"1","index":"1","fromtitle":"Epoxygenase","byteoffset":2849,"anchor":"CYP_epoxygenases"},{"toclevel":1,"level":"2","line":"CYP epoxygenase substrates and products","number":"2","index":"2","fromtitle":"Epoxygenase","byteoffset":9296,"anchor":"CYP_epoxygenase_substrates_and_products"},{"toclevel":1,"level":"2","line":"Omega-6 fatty acids","number":"3","index":"3","fromtitle":"Epoxygenase","byteoffset":13036,"anchor":"Omega-6_fatty_acids"},{"toclevel":2,"level":"3","line":"Arachidonic acid","number":"3.1","index":"4","fromtitle":"Epoxygenase","byteoffset":13061,"anchor":"Arachidonic_acid"},{"toclevel":2,"level":"3","line":"Linoleic acid","number":"3.2","index":"5","fromtitle":"Epoxygenase","byteoffset":16402,"anchor":"Linoleic_acid"},{"toclevel":2,"level":"3","line":"Adrenic acid","number":"3.3","index":"6","fromtitle":"Epoxygenase","byteoffset":22152,"anchor":"Adrenic_acid"},{"toclevel":1,"level":"2","line":"Omega-3 fatty acids","number":"4","index":"7","fromtitle":"Epoxygenase","byteoffset":23430,"anchor":"Omega-3_fatty_acids"},{"toclevel":2,"level":"3","line":"Eicosapentaenoic acid","number":"4.1","index":"8","fromtitle":"Epoxygenase","byteoffset":23455,"anchor":"Eicosapentaenoic_acid"},{"toclevel":2,"level":"3","line":"Docosahexaenoic acid","number":"4.2","index":"9","fromtitle":"Epoxygenase","byteoffset":24663,"anchor":"Docosahexaenoic_acid"},{"toclevel":2,"level":"3","line":"\u03b1-Linolenic acid","number":"4.3","index":"10","fromtitle":"Epoxygenase","byteoffset":26156,"anchor":"\u03b1-Linolenic_acid"},{"toclevel":1,"level":"2","line":"Genetic polymorphism in CYP epoxygenases","number":"5","index":"11","fromtitle":"Epoxygenase","byteoffset":27873,"anchor":"Genetic_polymorphism_in_CYP_epoxygenases"},{"toclevel":1,"level":"2","line":"Genetic polymorphism in Cytochrome P450 reductase","number":"6","index":"12","fromtitle":"Epoxygenase","byteoffset":40056,"anchor":"Genetic_polymorphism_in_Cytochrome_P450_reductase"},{"toclevel":1,"level":"2","line":"References","number":"7","index":"13","fromtitle":"Epoxygenase","byteoffset":41052,"anchor":"References"}],"parsewarnings":[],"displaytitle":"Epoxygenase","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q5383832"}]}}